| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | extracellular matrix structural constituent | 2.45e-08 | 188 | 72 | 9 | GO:0005201 | |
| GeneOntologyMolecularFunction | calcium ion binding | EYS SCUBE1 FBN1 FBN2 COMP MEGF6 LRP1 LRP2 DLK1 PLSCR2 DLL1 NOTCH1 NOTCH3 PADI3 NOTCH4 | 5.62e-08 | 749 | 72 | 15 | GO:0005509 |
| GeneOntologyMolecularFunction | retinoic acid 4-hydroxylase activity | 1.51e-07 | 14 | 72 | 4 | GO:0008401 | |
| GeneOntologyMolecularFunction | linoleic acid epoxygenase activity | 1.79e-07 | 4 | 72 | 3 | GO:0071614 | |
| GeneOntologyMolecularFunction | arachidonate epoxygenase activity | 1.56e-06 | 24 | 72 | 4 | GO:0008392 | |
| GeneOntologyMolecularFunction | oxidoreductase activity, acting on CH or CH2 groups, quinone or similar compound as acceptor | 2.48e-06 | 8 | 72 | 3 | GO:0033695 | |
| GeneOntologyMolecularFunction | caffeine oxidase activity | 2.48e-06 | 8 | 72 | 3 | GO:0034875 | |
| GeneOntologyMolecularFunction | arachidonate monooxygenase activity | 2.56e-06 | 27 | 72 | 4 | GO:0008391 | |
| GeneOntologyMolecularFunction | estrogen 16-alpha-hydroxylase activity | 7.26e-06 | 11 | 72 | 3 | GO:0101020 | |
| GeneOntologyMolecularFunction | aromatase activity | 7.48e-06 | 35 | 72 | 4 | GO:0070330 | |
| GeneOntologyMolecularFunction | (R)-limonene 6-monooxygenase activity | 1.28e-05 | 2 | 72 | 2 | GO:0052741 | |
| GeneOntologyMolecularFunction | limonene monooxygenase activity | 1.28e-05 | 2 | 72 | 2 | GO:0019113 | |
| GeneOntologyMolecularFunction | (S)-limonene 6-monooxygenase activity | 1.28e-05 | 2 | 72 | 2 | GO:0018675 | |
| GeneOntologyMolecularFunction | (S)-limonene 7-monooxygenase activity | 1.28e-05 | 2 | 72 | 2 | GO:0018676 | |
| GeneOntologyMolecularFunction | heme binding | 1.96e-05 | 154 | 72 | 6 | GO:0020037 | |
| GeneOntologyMolecularFunction | oxidoreductase activity, acting on CH or CH2 groups | 1.98e-05 | 15 | 72 | 3 | GO:0016725 | |
| GeneOntologyMolecularFunction | tetrapyrrole binding | 2.80e-05 | 164 | 72 | 6 | GO:0046906 | |
| GeneOntologyMolecularFunction | oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced flavin or flavoprotein as one donor, and incorporation of one atom of oxygen | 2.91e-05 | 49 | 72 | 4 | GO:0016712 | |
| GeneOntologyMolecularFunction | lactoperoxidase activity | 7.66e-05 | 4 | 72 | 2 | GO:0140825 | |
| GeneOntologyMolecularFunction | arachidonate 11,12-epoxygenase activity | 7.66e-05 | 4 | 72 | 2 | GO:0008405 | |
| GeneOntologyMolecularFunction | Notch binding | 1.24e-04 | 27 | 72 | 3 | GO:0005112 | |
| GeneOntologyMolecularFunction | fatty acid omega-1 hydroxylase activity | 1.27e-04 | 5 | 72 | 2 | GO:0120502 | |
| GeneOntologyMolecularFunction | long-chain fatty acid omega-1 hydroxylase activity | 1.27e-04 | 5 | 72 | 2 | GO:0120319 | |
| GeneOntologyMolecularFunction | arachidonate 14,15-epoxygenase activity | 1.27e-04 | 5 | 72 | 2 | GO:0008404 | |
| GeneOntologyMolecularFunction | ethanol binding | 1.91e-04 | 6 | 72 | 2 | GO:0035276 | |
| GeneOntologyMolecularFunction | steroid hydroxylase activity | 2.48e-04 | 34 | 72 | 3 | GO:0008395 | |
| GeneOntologyMolecularFunction | transition metal ion binding | SETMAR CYP2C19 CYP2C8 CYP2C9 CYP2C18 PRICKLE1 DBF4B NFX1 LHX3 PLSCR2 TRIM40 ADH1B ADH1C | 2.93e-04 | 1189 | 72 | 13 | GO:0046914 |
| GeneOntologyMolecularFunction | monooxygenase activity | 7.94e-04 | 115 | 72 | 4 | GO:0004497 | |
| GeneOntologyMolecularFunction | extracellular matrix constituent conferring elasticity | 8.27e-04 | 12 | 72 | 2 | GO:0030023 | |
| GeneOntologyMolecularFunction | structural molecule activity conferring elasticity | 1.13e-03 | 14 | 72 | 2 | GO:0097493 | |
| GeneOntologyMolecularFunction | low-density lipoprotein particle receptor activity | 1.49e-03 | 16 | 72 | 2 | GO:0005041 | |
| GeneOntologyMolecularFunction | oxidoreductase activity | 1.68e-03 | 766 | 72 | 9 | GO:0016491 | |
| GeneOntologyMolecularFunction | C2H2 zinc finger domain binding | 1.68e-03 | 17 | 72 | 2 | GO:0070742 | |
| GeneOntologyMolecularFunction | NAD binding | 2.33e-03 | 73 | 72 | 3 | GO:0051287 | |
| GeneOntologyMolecularFunction | lipoprotein particle receptor activity | 2.58e-03 | 21 | 72 | 2 | GO:0030228 | |
| GeneOntologyMolecularFunction | iron ion binding | 3.05e-03 | 166 | 72 | 4 | GO:0005506 | |
| GeneOntologyMolecularFunction | phospholipid scramblase activity | 3.09e-03 | 23 | 72 | 2 | GO:0017128 | |
| GeneOntologyMolecularFunction | all-trans-retinol dehydrogenase (NAD+) activity | 3.36e-03 | 24 | 72 | 2 | GO:0004745 | |
| GeneOntologyMolecularFunction | zinc ion transmembrane transporter activity | 3.36e-03 | 24 | 72 | 2 | GO:0005385 | |
| GeneOntologyMolecularFunction | integrin binding | 3.69e-03 | 175 | 72 | 4 | GO:0005178 | |
| GeneOntologyMolecularFunction | alcohol dehydrogenase (NAD+) activity | 3.94e-03 | 26 | 72 | 2 | GO:0004022 | |
| GeneOntologyMolecularFunction | structural molecule activity | 4.61e-03 | 891 | 72 | 9 | GO:0005198 | |
| GeneOntologyMolecularFunction | zinc ion binding | 4.61e-03 | 891 | 72 | 9 | GO:0008270 | |
| GeneOntologyMolecularFunction | heparan sulfate proteoglycan binding | 4.89e-03 | 29 | 72 | 2 | GO:0043395 | |
| GeneOntologyMolecularFunction | alcohol dehydrogenase [NAD(P)+] activity | 5.22e-03 | 30 | 72 | 2 | GO:0018455 | |
| GeneOntologyMolecularFunction | oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen | 5.31e-03 | 194 | 72 | 4 | GO:0016705 | |
| GeneOntologyMolecularFunction | oxygen binding | 7.87e-03 | 37 | 72 | 2 | GO:0019825 | |
| GeneOntologyMolecularFunction | lipoprotein particle receptor binding | 8.72e-03 | 39 | 72 | 2 | GO:0070325 | |
| GeneOntologyBiologicalProcess | terpenoid metabolic process | 2.81e-09 | 105 | 71 | 8 | GO:0006721 | |
| GeneOntologyBiologicalProcess | artery development | 1.83e-08 | 133 | 71 | 8 | GO:0060840 | |
| GeneOntologyBiologicalProcess | artery morphogenesis | 2.94e-08 | 92 | 71 | 7 | GO:0048844 | |
| GeneOntologyBiologicalProcess | isoprenoid metabolic process | 3.41e-08 | 144 | 71 | 8 | GO:0006720 | |
| GeneOntologyBiologicalProcess | retinoid metabolic process | 6.22e-07 | 89 | 71 | 6 | GO:0001523 | |
| GeneOntologyBiologicalProcess | diterpenoid metabolic process | 8.60e-07 | 94 | 71 | 6 | GO:0016101 | |
| GeneOntologyBiologicalProcess | epoxygenase P450 pathway | 9.00e-07 | 22 | 71 | 4 | GO:0019373 | |
| GeneOntologyBiologicalProcess | axon guidance | 6.03e-06 | 285 | 71 | 8 | GO:0007411 | |
| GeneOntologyBiologicalProcess | neuron projection guidance | 6.19e-06 | 286 | 71 | 8 | GO:0097485 | |
| GeneOntologyBiologicalProcess | aorta development | 8.24e-06 | 80 | 71 | 5 | GO:0035904 | |
| GeneOntologyBiologicalProcess | retinoic acid metabolic process | 1.07e-05 | 40 | 71 | 4 | GO:0042573 | |
| GeneOntologyBiologicalProcess | alcohol metabolic process | 1.16e-05 | 412 | 71 | 9 | GO:0006066 | |
| GeneOntologyBiologicalProcess | omega-hydroxylase P450 pathway | 1.38e-05 | 14 | 71 | 3 | GO:0097267 | |
| GeneOntologyBiologicalProcess | neuron fate commitment | 1.55e-05 | 91 | 71 | 5 | GO:0048663 | |
| GeneOntologyBiologicalProcess | tube development | WDR19 FNDC3B FBN1 PXDN COMP PRICKLE1 LAMA1 LRP1 LRP2 LAMA5 ADGRF5 LHX3 DLL1 NOTCH1 NOTCH3 NOTCH4 | 1.72e-05 | 1402 | 71 | 16 | GO:0035295 |
| GeneOntologyBiologicalProcess | retinol metabolic process | 3.32e-05 | 53 | 71 | 4 | GO:0042572 | |
| GeneOntologyBiologicalProcess | detoxification of zinc ion | 3.50e-05 | 3 | 71 | 2 | GO:0010312 | |
| GeneOntologyBiologicalProcess | acetaldehyde biosynthetic process | 3.50e-05 | 3 | 71 | 2 | GO:0046186 | |
| GeneOntologyBiologicalProcess | stress response to zinc ion | 3.50e-05 | 3 | 71 | 2 | GO:1990359 | |
| GeneOntologyBiologicalProcess | olefinic compound metabolic process | 3.64e-05 | 180 | 71 | 6 | GO:0120254 | |
| GeneOntologyBiologicalProcess | regulation of Notch signaling pathway | 4.60e-05 | 114 | 71 | 5 | GO:0008593 | |
| GeneOntologyBiologicalProcess | spinal cord development | 5.64e-05 | 119 | 71 | 5 | GO:0021510 | |
| GeneOntologyBiologicalProcess | dorsal spinal cord development | 5.74e-05 | 22 | 71 | 3 | GO:0021516 | |
| GeneOntologyBiologicalProcess | BMP signaling pathway | 6.01e-05 | 197 | 71 | 6 | GO:0030509 | |
| GeneOntologyBiologicalProcess | linoleic acid metabolic process | 6.59e-05 | 23 | 71 | 3 | GO:0043651 | |
| GeneOntologyBiologicalProcess | positive regulation of aorta morphogenesis | 6.98e-05 | 4 | 71 | 2 | GO:1903849 | |
| GeneOntologyBiologicalProcess | sequestering of TGFbeta in extracellular matrix | 6.98e-05 | 4 | 71 | 2 | GO:0035583 | |
| GeneOntologyBiologicalProcess | regulation of cellular response to growth factor stimulus | 8.39e-05 | 412 | 71 | 8 | GO:0090287 | |
| GeneOntologyBiologicalProcess | Notch signaling pathway | 8.56e-05 | 210 | 71 | 6 | GO:0007219 | |
| GeneOntologyBiologicalProcess | arachidonate metabolic process | 8.89e-05 | 68 | 71 | 4 | GO:0019369 | |
| GeneOntologyBiologicalProcess | regulation of BMP signaling pathway | 8.91e-05 | 131 | 71 | 5 | GO:0030510 | |
| GeneOntologyBiologicalProcess | response to BMP | 9.74e-05 | 215 | 71 | 6 | GO:0071772 | |
| GeneOntologyBiologicalProcess | cellular response to BMP stimulus | 9.74e-05 | 215 | 71 | 6 | GO:0071773 | |
| GeneOntologyBiologicalProcess | negative regulation of transmembrane receptor protein serine/threonine kinase signaling pathway | 1.05e-04 | 218 | 71 | 6 | GO:0090101 | |
| GeneOntologyBiologicalProcess | positive regulation of lysosomal protein catabolic process | 1.16e-04 | 5 | 71 | 2 | GO:1905167 | |
| GeneOntologyBiologicalProcess | negative regulation of inner ear receptor cell differentiation | 1.16e-04 | 5 | 71 | 2 | GO:2000981 | |
| GeneOntologyBiologicalProcess | chemoattraction of axon | 1.16e-04 | 5 | 71 | 2 | GO:0061642 | |
| GeneOntologyBiologicalProcess | acetaldehyde metabolic process | 1.16e-04 | 5 | 71 | 2 | GO:0006117 | |
| GeneOntologyBiologicalProcess | compartment pattern specification | 1.16e-04 | 5 | 71 | 2 | GO:0007386 | |
| GeneOntologyBiologicalProcess | negative regulation of inner ear auditory receptor cell differentiation | 1.16e-04 | 5 | 71 | 2 | GO:0045608 | |
| GeneOntologyBiologicalProcess | negative regulation of mechanoreceptor differentiation | 1.16e-04 | 5 | 71 | 2 | GO:0045632 | |
| GeneOntologyBiologicalProcess | axonogenesis | 1.36e-04 | 566 | 71 | 9 | GO:0007409 | |
| GeneOntologyBiologicalProcess | transforming growth factor beta receptor superfamily signaling pathway | 1.43e-04 | 445 | 71 | 8 | GO:0141091 | |
| GeneOntologyBiologicalProcess | cell fate commitment | 1.61e-04 | 338 | 71 | 7 | GO:0045165 | |
| GeneOntologyBiologicalProcess | negative regulation of BMP signaling pathway | 1.67e-04 | 80 | 71 | 4 | GO:0030514 | |
| GeneOntologyBiologicalProcess | inner ear receptor cell fate commitment | 1.74e-04 | 6 | 71 | 2 | GO:0060120 | |
| GeneOntologyBiologicalProcess | regulation of aorta morphogenesis | 1.74e-04 | 6 | 71 | 2 | GO:1903847 | |
| GeneOntologyBiologicalProcess | monoterpenoid metabolic process | 1.74e-04 | 6 | 71 | 2 | GO:0016098 | |
| GeneOntologyBiologicalProcess | auditory receptor cell fate commitment | 1.74e-04 | 6 | 71 | 2 | GO:0009912 | |
| GeneOntologyBiologicalProcess | inhibition of neuroepithelial cell differentiation | 1.74e-04 | 6 | 71 | 2 | GO:0002085 | |
| GeneOntologyBiologicalProcess | arterial endothelial cell differentiation | 1.74e-04 | 6 | 71 | 2 | GO:0060842 | |
| GeneOntologyBiologicalProcess | regulation of transmembrane receptor protein serine/threonine kinase signaling pathway | 1.90e-04 | 347 | 71 | 7 | GO:0090092 | |
| GeneOntologyBiologicalProcess | coronary vasculature development | 1.93e-04 | 83 | 71 | 4 | GO:0060976 | |
| GeneOntologyBiologicalProcess | hydrogen peroxide catabolic process | 1.98e-04 | 33 | 71 | 3 | GO:0042744 | |
| GeneOntologyBiologicalProcess | negative regulation of myoblast differentiation | 2.17e-04 | 34 | 71 | 3 | GO:0045662 | |
| GeneOntologyBiologicalProcess | cell morphogenesis involved in neuron differentiation | PRICKLE1 LAMA1 DRGX LRP1 LRP2 LAMA5 LHX3 SLC30A1 NOTCH1 NOTCH3 | 2.32e-04 | 748 | 71 | 10 | GO:0048667 |
| GeneOntologyBiologicalProcess | regionalization | 2.32e-04 | 478 | 71 | 8 | GO:0003002 | |
| GeneOntologyBiologicalProcess | positive regulation of protein catabolic process in the vacuole | 2.43e-04 | 7 | 71 | 2 | GO:1904352 | |
| GeneOntologyBiologicalProcess | positive regulation of transcription of Notch receptor target | 2.43e-04 | 7 | 71 | 2 | GO:0007221 | |
| GeneOntologyBiologicalProcess | regulation of somitogenesis | 2.43e-04 | 7 | 71 | 2 | GO:0014807 | |
| GeneOntologyBiologicalProcess | cell surface receptor protein serine/threonine kinase signaling pathway | 2.46e-04 | 482 | 71 | 8 | GO:0007178 | |
| GeneOntologyBiologicalProcess | negative regulation of osteoblast differentiation | 2.63e-04 | 90 | 71 | 4 | GO:0045668 | |
| GeneOntologyBiologicalProcess | xenobiotic catabolic process | 2.79e-04 | 37 | 71 | 3 | GO:0042178 | |
| GeneOntologyBiologicalProcess | detoxification | 3.01e-04 | 170 | 71 | 5 | GO:0098754 | |
| GeneOntologyBiologicalProcess | negative regulation of neuron differentiation | 3.11e-04 | 94 | 71 | 4 | GO:0045665 | |
| GeneOntologyBiologicalProcess | extracellular matrix organization | 3.14e-04 | 377 | 71 | 7 | GO:0030198 | |
| GeneOntologyBiologicalProcess | blood vessel development | PXDN COMP PRICKLE1 LAMA1 LRP1 LRP2 ADGRF5 DLL1 NOTCH1 NOTCH3 NOTCH4 | 3.14e-04 | 929 | 71 | 11 | GO:0001568 |
| GeneOntologyBiologicalProcess | extracellular structure organization | 3.19e-04 | 378 | 71 | 7 | GO:0043062 | |
| GeneOntologyBiologicalProcess | maintenance of protein location in extracellular region | 3.23e-04 | 8 | 71 | 2 | GO:0071694 | |
| GeneOntologyBiologicalProcess | external encapsulating structure organization | 3.24e-04 | 379 | 71 | 7 | GO:0045229 | |
| GeneOntologyBiologicalProcess | lung development | 3.28e-04 | 269 | 71 | 6 | GO:0030324 | |
| GeneOntologyBiologicalProcess | organic hydroxy compound metabolic process | 3.41e-04 | 641 | 71 | 9 | GO:1901615 | |
| GeneOntologyBiologicalProcess | axon development | 3.45e-04 | 642 | 71 | 9 | GO:0061564 | |
| GeneOntologyBiologicalProcess | circulatory system development | SCUBE1 ADRA1A FBN1 PXDN COMP PRICKLE1 LAMA1 LRP1 LRP2 ADGRF5 DLL1 NOTCH1 NOTCH3 NOTCH4 | 3.47e-04 | 1442 | 71 | 14 | GO:0072359 |
| GeneOntologyBiologicalProcess | respiratory tube development | 3.55e-04 | 273 | 71 | 6 | GO:0030323 | |
| GeneOntologyBiologicalProcess | renal system development | 3.62e-04 | 386 | 71 | 7 | GO:0072001 | |
| GeneOntologyBiologicalProcess | regulation of embryonic development | 3.79e-04 | 99 | 71 | 4 | GO:0045995 | |
| GeneOntologyBiologicalProcess | aorta morphogenesis | 3.79e-04 | 41 | 71 | 3 | GO:0035909 | |
| GeneOntologyBiologicalProcess | neuron projection morphogenesis | PRICKLE1 LAMA1 DRGX LRP1 LRP2 LAMA5 LHX3 SLC30A1 NOTCH1 NOTCH3 | 4.03e-04 | 802 | 71 | 10 | GO:0048812 |
| GeneOntologyBiologicalProcess | neuron fate specification | 4.08e-04 | 42 | 71 | 3 | GO:0048665 | |
| GeneOntologyBiologicalProcess | positive regulation of artery morphogenesis | 4.14e-04 | 9 | 71 | 2 | GO:1905653 | |
| GeneOntologyBiologicalProcess | tube morphogenesis | PXDN COMP PRICKLE1 LAMA1 LRP1 LRP2 LAMA5 ADGRF5 DLL1 NOTCH1 NOTCH3 NOTCH4 | 4.23e-04 | 1125 | 71 | 12 | GO:0035239 |
| GeneOntologyBiologicalProcess | basement membrane organization | 4.37e-04 | 43 | 71 | 3 | GO:0071711 | |
| GeneOntologyBiologicalProcess | pattern specification process | 4.41e-04 | 526 | 71 | 8 | GO:0007389 | |
| GeneOntologyBiologicalProcess | vasculature development | PXDN COMP PRICKLE1 LAMA1 LRP1 LRP2 ADGRF5 DLL1 NOTCH1 NOTCH3 NOTCH4 | 4.49e-04 | 969 | 71 | 11 | GO:0001944 |
| GeneOntologyBiologicalProcess | blood vessel morphogenesis | 4.66e-04 | 817 | 71 | 10 | GO:0048514 | |
| GeneOntologyBiologicalProcess | plasma membrane bounded cell projection morphogenesis | PRICKLE1 LAMA1 DRGX LRP1 LRP2 LAMA5 LHX3 SLC30A1 NOTCH1 NOTCH3 | 4.75e-04 | 819 | 71 | 10 | GO:0120039 |
| GeneOntologyBiologicalProcess | primary alcohol metabolic process | 4.91e-04 | 106 | 71 | 4 | GO:0034308 | |
| GeneOntologyBiologicalProcess | cell projection morphogenesis | PRICKLE1 LAMA1 DRGX LRP1 LRP2 LAMA5 LHX3 SLC30A1 NOTCH1 NOTCH3 | 5.07e-04 | 826 | 71 | 10 | GO:0048858 |
| GeneOntologyBiologicalProcess | coronary artery morphogenesis | 5.16e-04 | 10 | 71 | 2 | GO:0060982 | |
| GeneOntologyBiologicalProcess | negative regulation of cell-cell adhesion mediated by cadherin | 5.16e-04 | 10 | 71 | 2 | GO:2000048 | |
| GeneOntologyBiologicalProcess | regulation of osteoblast differentiation | 5.25e-04 | 192 | 71 | 5 | GO:0045667 | |
| GeneOntologyBiologicalProcess | negative regulation of Notch signaling pathway | 6.05e-04 | 48 | 71 | 3 | GO:0045746 | |
| GeneOntologyBiologicalProcess | epithelial tube morphogenesis | 6.07e-04 | 421 | 71 | 7 | GO:0060562 | |
| GeneOntologyBiologicalProcess | sequestering of extracellular ligand from receptor | 6.30e-04 | 11 | 71 | 2 | GO:0035581 | |
| GeneOntologyBiologicalProcess | zinc ion import into organelle | 6.30e-04 | 11 | 71 | 2 | GO:0062111 | |
| GeneOntologyBiologicalProcess | respiratory system development | 6.36e-04 | 305 | 71 | 6 | GO:0060541 | |
| GeneOntologyBiologicalProcess | biomineral tissue development | 6.76e-04 | 203 | 71 | 5 | GO:0031214 | |
| GeneOntologyBiologicalProcess | muscle structure development | ADRA1A COMP PRICKLE1 LAMA1 LRP2 LAMA5 DLL1 ZBTB42 NOTCH1 NOTCH4 | 6.81e-04 | 858 | 71 | 10 | GO:0061061 |
| GeneOntologyBiologicalProcess | renal tubule development | 6.90e-04 | 116 | 71 | 4 | GO:0061326 | |
| GeneOntologyCellularComponent | collagen-containing extracellular matrix | EYS FBN1 FBN2 VWF PXDN COMP MEGF6 COL28A1 LAMA1 LAMA5 PLSCR2 | 1.62e-06 | 530 | 71 | 11 | GO:0062023 |
| GeneOntologyCellularComponent | extracellular matrix | EYS FBN1 FBN2 VWF PXDN COMP MEGF6 COL28A1 LAMA1 LAMA5 PLSCR2 MUC5AC | 1.94e-06 | 656 | 71 | 12 | GO:0031012 |
| GeneOntologyCellularComponent | external encapsulating structure | EYS FBN1 FBN2 VWF PXDN COMP MEGF6 COL28A1 LAMA1 LAMA5 PLSCR2 MUC5AC | 2.00e-06 | 658 | 71 | 12 | GO:0030312 |
| GeneOntologyCellularComponent | basement membrane | 5.97e-05 | 122 | 71 | 5 | GO:0005604 | |
| GeneOntologyCellularComponent | laminin complex | 5.03e-04 | 10 | 71 | 2 | GO:0043256 | |
| GeneOntologyCellularComponent | microfibril | 8.66e-04 | 13 | 71 | 2 | GO:0001527 | |
| Domain | Growth_fac_rcpt_ | ELAPOR2 EYS SCUBE1 FBN1 FBN2 COMP CRIM1 MEGF6 LAMA1 LRP1 LRP2 LAMA5 DLL1 NOTCH1 NOTCH3 NOTCH4 | 7.05e-19 | 156 | 72 | 16 | IPR009030 |
| Domain | EGF | EYS SCUBE1 FBN1 FBN2 COMP MEGF6 LAMA1 LRP1 LRP2 LAMA5 DLK1 DLL1 NOTCH1 NOTCH3 NOTCH4 PEAR1 | 5.21e-16 | 235 | 72 | 16 | SM00181 |
| Domain | EGF_CA | EYS SCUBE1 FBN1 FBN2 COMP MEGF6 LRP1 LRP2 DLK1 DLL1 NOTCH1 NOTCH3 NOTCH4 | 1.05e-15 | 122 | 72 | 13 | SM00179 |
| Domain | EGF-like_dom | EYS SCUBE1 FBN1 FBN2 COMP MEGF6 LAMA1 LRP1 LRP2 LAMA5 DLK1 DLL1 NOTCH1 NOTCH3 NOTCH4 PEAR1 | 1.30e-15 | 249 | 72 | 16 | IPR000742 |
| Domain | EGF-like_Ca-bd_dom | EYS SCUBE1 FBN1 FBN2 COMP MEGF6 LRP1 LRP2 DLK1 DLL1 NOTCH1 NOTCH3 NOTCH4 | 1.30e-15 | 124 | 72 | 13 | IPR001881 |
| Domain | EGF_1 | EYS SCUBE1 FBN1 FBN2 COMP MEGF6 LAMA1 LRP1 LRP2 LAMA5 DLK1 DLL1 NOTCH1 NOTCH3 NOTCH4 PEAR1 | 1.89e-15 | 255 | 72 | 16 | PS00022 |
| Domain | EGF_Ca-bd_CS | EYS SCUBE1 FBN1 FBN2 COMP MEGF6 LRP1 LRP2 DLL1 NOTCH1 NOTCH3 NOTCH4 | 2.27e-15 | 97 | 72 | 12 | IPR018097 |
| Domain | EGF-like_CS | EYS SCUBE1 FBN1 FBN2 COMP MEGF6 LAMA1 LRP1 LRP2 LAMA5 DLK1 DLL1 NOTCH1 NOTCH3 NOTCH4 PEAR1 | 2.73e-15 | 261 | 72 | 16 | IPR013032 |
| Domain | EGF_CA | EYS SCUBE1 FBN1 FBN2 COMP MEGF6 LRP1 LRP2 DLL1 NOTCH1 NOTCH3 NOTCH4 | 2.92e-15 | 99 | 72 | 12 | PS01187 |
| Domain | ASX_HYDROXYL | EYS SCUBE1 FBN1 FBN2 MEGF6 LRP1 LRP2 DLK1 DLL1 NOTCH1 NOTCH3 NOTCH4 | 3.31e-15 | 100 | 72 | 12 | PS00010 |
| Domain | EGF_2 | EYS SCUBE1 FBN1 FBN2 COMP MEGF6 LAMA1 LRP1 LRP2 LAMA5 DLK1 DLL1 NOTCH1 NOTCH3 NOTCH4 PEAR1 | 3.47e-15 | 265 | 72 | 16 | PS01186 |
| Domain | EGF-type_Asp/Asn_hydroxyl_site | EYS SCUBE1 FBN1 FBN2 MEGF6 LRP1 LRP2 DLK1 DLL1 NOTCH1 NOTCH3 NOTCH4 | 6.82e-15 | 106 | 72 | 12 | IPR000152 |
| Domain | EGF_3 | EYS SCUBE1 FBN1 FBN2 COMP MEGF6 LRP1 LRP2 DLK1 DLL1 NOTCH1 NOTCH3 NOTCH4 PEAR1 | 2.65e-13 | 235 | 72 | 14 | PS50026 |
| Domain | EGF_CA | 1.06e-12 | 86 | 72 | 10 | PF07645 | |
| Domain | hEGF | 1.04e-11 | 28 | 72 | 7 | PF12661 | |
| Domain | EGF | 1.29e-09 | 126 | 72 | 9 | PF00008 | |
| Domain | cEGF | 4.57e-08 | 26 | 72 | 5 | IPR026823 | |
| Domain | cEGF | 4.57e-08 | 26 | 72 | 5 | PF12662 | |
| Domain | VWC | 6.78e-08 | 28 | 72 | 5 | PF00093 | |
| Domain | Notch | 2.19e-07 | 4 | 72 | 3 | IPR008297 | |
| Domain | NODP | 2.19e-07 | 4 | 72 | 3 | PF07684 | |
| Domain | Notch_NODP_dom | 2.19e-07 | 4 | 72 | 3 | IPR011656 | |
| Domain | Notch_NOD_dom | 2.19e-07 | 4 | 72 | 3 | IPR010660 | |
| Domain | NOD | 2.19e-07 | 4 | 72 | 3 | PF06816 | |
| Domain | NOD | 2.19e-07 | 4 | 72 | 3 | SM01338 | |
| Domain | NODP | 2.19e-07 | 4 | 72 | 3 | SM01339 | |
| Domain | VWFC_1 | 2.54e-07 | 36 | 72 | 5 | PS01208 | |
| Domain | VWC | 3.36e-07 | 38 | 72 | 5 | SM00214 | |
| Domain | VWFC_2 | 3.36e-07 | 38 | 72 | 5 | PS50184 | |
| Domain | LNR | 5.46e-07 | 5 | 72 | 3 | PS50258 | |
| Domain | VWF_dom | 5.63e-07 | 42 | 72 | 5 | IPR001007 | |
| Domain | Notch_dom | 1.90e-06 | 7 | 72 | 3 | IPR000800 | |
| Domain | Notch | 1.90e-06 | 7 | 72 | 3 | PF00066 | |
| Domain | Hirudin/antistatin | 1.90e-06 | 7 | 72 | 3 | IPR011061 | |
| Domain | NL | 1.90e-06 | 7 | 72 | 3 | SM00004 | |
| Domain | EGF_extracell | 3.42e-06 | 60 | 72 | 5 | IPR013111 | |
| Domain | EGF_2 | 3.42e-06 | 60 | 72 | 5 | PF07974 | |
| Domain | Laminin_EGF | 9.71e-06 | 35 | 72 | 4 | PF00053 | |
| Domain | EGF_Lam | 9.71e-06 | 35 | 72 | 4 | SM00180 | |
| Domain | Laminin_EGF | 1.36e-05 | 38 | 72 | 4 | IPR002049 | |
| Domain | TIL_dom | 1.94e-05 | 14 | 72 | 3 | IPR002919 | |
| Domain | Cyt_P450_E_grp-I | 2.68e-05 | 45 | 72 | 4 | IPR002401 | |
| Domain | DUF3454 | 4.39e-05 | 3 | 72 | 2 | PF11936 | |
| Domain | DUF3454_notch | 4.39e-05 | 3 | 72 | 2 | IPR024600 | |
| Domain | DUF3454 | 4.39e-05 | 3 | 72 | 2 | SM01334 | |
| Domain | FBN | 4.39e-05 | 3 | 72 | 2 | IPR011398 | |
| Domain | VWC_out | 5.09e-05 | 19 | 72 | 3 | SM00215 | |
| Domain | Cyt_P450_CS | 5.15e-05 | 53 | 72 | 4 | IPR017972 | |
| Domain | CYTOCHROME_P450 | 6.87e-05 | 57 | 72 | 4 | PS00086 | |
| Domain | - | 7.36e-05 | 58 | 72 | 4 | 1.10.630.10 | |
| Domain | p450 | 7.36e-05 | 58 | 72 | 4 | PF00067 | |
| Domain | Cyt_P450 | 8.41e-05 | 60 | 72 | 4 | IPR001128 | |
| Domain | Laminin_aI | 1.45e-04 | 5 | 72 | 2 | IPR009254 | |
| Domain | Laminin_I | 1.45e-04 | 5 | 72 | 2 | PF06008 | |
| Domain | Laminin_II | 1.45e-04 | 5 | 72 | 2 | PF06009 | |
| Domain | Laminin_domII | 1.45e-04 | 5 | 72 | 2 | IPR010307 | |
| Domain | Scramblase | 1.45e-04 | 5 | 72 | 2 | PF03803 | |
| Domain | Scramblase | 1.45e-04 | 5 | 72 | 2 | IPR005552 | |
| Domain | PEROXIDASE_1 | 2.18e-04 | 6 | 72 | 2 | PS00435 | |
| Domain | TB | 3.04e-04 | 7 | 72 | 2 | PF00683 | |
| Domain | LAMININ_IVA | 4.04e-04 | 8 | 72 | 2 | PS51115 | |
| Domain | Laminin_B | 4.04e-04 | 8 | 72 | 2 | PF00052 | |
| Domain | - | 4.04e-04 | 8 | 72 | 2 | 3.90.290.10 | |
| Domain | LamB | 4.04e-04 | 8 | 72 | 2 | SM00281 | |
| Domain | ADH_Zn_CS | 4.04e-04 | 8 | 72 | 2 | IPR002328 | |
| Domain | Laminin_IV | 4.04e-04 | 8 | 72 | 2 | IPR000034 | |
| Domain | ADH_ZINC | 4.04e-04 | 8 | 72 | 2 | PS00059 | |
| Domain | LAM_G_DOMAIN | 4.21e-04 | 38 | 72 | 3 | PS50025 | |
| Domain | Laminin_G_2 | 4.90e-04 | 40 | 72 | 3 | PF02210 | |
| Domain | - | 4.96e-04 | 95 | 72 | 4 | 2.60.120.200 | |
| Domain | TB | 5.18e-04 | 9 | 72 | 2 | PS51364 | |
| Domain | TB_dom | 5.18e-04 | 9 | 72 | 2 | IPR017878 | |
| Domain | Cation_efflux | 6.46e-04 | 10 | 72 | 2 | IPR002524 | |
| Domain | Haem_peroxidase | 6.46e-04 | 10 | 72 | 2 | IPR010255 | |
| Domain | An_peroxidase | 6.46e-04 | 10 | 72 | 2 | PF03098 | |
| Domain | Cation_efflux | 6.46e-04 | 10 | 72 | 2 | PF01545 | |
| Domain | PEROXIDASE_3 | 6.46e-04 | 10 | 72 | 2 | PS50292 | |
| Domain | Haem_peroxidase_animal | 6.46e-04 | 10 | 72 | 2 | IPR019791 | |
| Domain | - | 6.46e-04 | 10 | 72 | 2 | 1.10.640.10 | |
| Domain | LamG | 6.50e-04 | 44 | 72 | 3 | SM00282 | |
| Domain | - | 7.88e-04 | 11 | 72 | 2 | 1.20.1510.10 | |
| Domain | Laminin_G_1 | 7.88e-04 | 11 | 72 | 2 | PF00054 | |
| Domain | Cation_efflux_TMD | 7.88e-04 | 11 | 72 | 2 | IPR027469 | |
| Domain | TIL | 9.43e-04 | 12 | 72 | 2 | PF01826 | |
| Domain | C8 | 9.43e-04 | 12 | 72 | 2 | PF08742 | |
| Domain | Unchr_dom_Cys-rich | 1.11e-03 | 13 | 72 | 2 | IPR014853 | |
| Domain | C8 | 1.11e-03 | 13 | 72 | 2 | SM00832 | |
| Domain | Ldl_recept_b | 1.29e-03 | 14 | 72 | 2 | PF00058 | |
| Domain | LDLRB | 1.29e-03 | 14 | 72 | 2 | PS51120 | |
| Domain | Laminin_G | 1.46e-03 | 58 | 72 | 3 | IPR001791 | |
| Domain | LY | 1.49e-03 | 15 | 72 | 2 | SM00135 | |
| Domain | LDLR_classB_rpt | 1.49e-03 | 15 | 72 | 2 | IPR000033 | |
| Domain | ADH_N | 1.70e-03 | 16 | 72 | 2 | PF08240 | |
| Domain | VWD | 1.70e-03 | 16 | 72 | 2 | SM00216 | |
| Domain | EMI_domain | 1.70e-03 | 16 | 72 | 2 | IPR011489 | |
| Domain | VWF_type-D | 1.70e-03 | 16 | 72 | 2 | IPR001846 | |
| Domain | Laminin_N | 1.70e-03 | 16 | 72 | 2 | IPR008211 | |
| Domain | PKS_ER | 1.70e-03 | 16 | 72 | 2 | SM00829 | |
| Domain | LAMININ_NTER | 1.70e-03 | 16 | 72 | 2 | PS51117 | |
| Domain | VWFD | 1.70e-03 | 16 | 72 | 2 | PS51233 | |
| Pathway | WP_CANONICAL_AND_NONCANONICAL_NOTCH_SIGNALING | 3.14e-08 | 27 | 49 | 5 | M39545 | |
| Pathway | KEGG_RETINOL_METABOLISM | 8.27e-08 | 64 | 49 | 6 | M9488 | |
| Pathway | KEGG_MEDICUS_REFERENCE_NOTCH_SIGNALING_PATHWAY | 9.00e-08 | 13 | 49 | 4 | M47423 | |
| Pathway | KEGG_MEDICUS_PATHOGEN_HPV_E6_TO_NOTCH_SIGNALING_PATHWAY_N00382 | 9.00e-08 | 13 | 49 | 4 | M47534 | |
| Pathway | KEGG_METABOLISM_OF_XENOBIOTICS_BY_CYTOCHROME_P450 | 1.42e-07 | 70 | 49 | 6 | M16794 | |
| Pathway | KEGG_DRUG_METABOLISM_CYTOCHROME_P450 | 1.69e-07 | 72 | 49 | 6 | M9257 | |
| Pathway | REACTOME_DEFECTIVE_LFNG_CAUSES_SCDO3 | 3.93e-07 | 5 | 49 | 3 | M27411 | |
| Pathway | REACTOME_PRE_NOTCH_PROCESSING_IN_GOLGI | 3.93e-07 | 5 | 49 | 3 | MM14733 | |
| Pathway | REACTOME_EXTRACELLULAR_MATRIX_ORGANIZATION | 7.73e-07 | 300 | 49 | 9 | M610 | |
| Pathway | REACTOME_PRE_NOTCH_PROCESSING_IN_THE_ENDOPLASMIC_RETICULUM | 7.84e-07 | 6 | 49 | 3 | M27068 | |
| Pathway | REACTOME_XENOBIOTICS | 1.09e-06 | 23 | 49 | 4 | M5372 | |
| Pathway | REACTOME_PRE_NOTCH_EXPRESSION_AND_PROCESSING | 1.37e-06 | 7 | 49 | 3 | MM14734 | |
| Pathway | REACTOME_PHASE_I_FUNCTIONALIZATION_OF_COMPOUNDS | 1.51e-06 | 104 | 49 | 6 | M738 | |
| Pathway | PID_NOTCH_PATHWAY | 1.79e-06 | 59 | 49 | 5 | M17 | |
| Pathway | REACTOME_SYNTHESIS_OF_EPOXY_EET_AND_DIHYDROXYEICOSATRIENOIC_ACIDS_DHET | 2.18e-06 | 8 | 49 | 3 | M27135 | |
| Pathway | REACTOME_EXTRACELLULAR_MATRIX_ORGANIZATION | 2.66e-06 | 258 | 49 | 8 | MM14572 | |
| Pathway | KEGG_LINOLEIC_ACID_METABOLISM | 2.87e-06 | 29 | 49 | 4 | M2920 | |
| Pathway | REACTOME_SYNTHESIS_OF_16_20_HYDROXYEICOSATETRAENOIC_ACIDS_HETE | 3.27e-06 | 9 | 49 | 3 | M27143 | |
| Pathway | REACTOME_CYP2E1_REACTIONS | 6.39e-06 | 11 | 49 | 3 | M27130 | |
| Pathway | KEGG_MEDICUS_REFERENCE_NOTCH_PROTEOLYTIC_ACTIVATION | 6.39e-06 | 11 | 49 | 3 | M47865 | |
| Pathway | WP_OCTADECANOID_FORMATION_FROM_LINOLEIC_ACID | 8.49e-06 | 12 | 49 | 3 | M48064 | |
| Pathway | KEGG_MEDICUS_PATHOGEN_HPV_E6_TO_NOTCH_SIGNALING_PATHWAY_N00380 | 8.49e-06 | 12 | 49 | 3 | M47532 | |
| Pathway | KEGG_MEDICUS_PATHOGEN_HPV_E6_TO_NOTCH_SIGNALING_PATHWAY_N00381 | 8.49e-06 | 12 | 49 | 3 | M47533 | |
| Pathway | REACTOME_SIGNALING_BY_NOTCH | 9.69e-06 | 39 | 49 | 4 | MM14604 | |
| Pathway | WP_EICOSANOID_METABOLISM_VIA_CYTOCHROME_P450_MONOOXYGENASES | 1.40e-05 | 14 | 49 | 3 | MM15842 | |
| Pathway | WP_NOTCH_SIGNALING_WP268 | 1.73e-05 | 45 | 49 | 4 | M39571 | |
| Pathway | WP_NOTCH_SIGNALING_PATHWAY | 1.89e-05 | 46 | 49 | 4 | MM15971 | |
| Pathway | KEGG_NOTCH_SIGNALING_PATHWAY | 2.06e-05 | 47 | 49 | 4 | M7946 | |
| Pathway | KEGG_MEDICUS_VARIANT_NOTCH_OVEREXPRESSION_TO_NOTCH_SIGNALING_PATHWAY | 2.14e-05 | 16 | 49 | 3 | M47424 | |
| Pathway | REACTOME_PHASE_I_FUNCTIONALIZATION_OF_COMPOUNDS | 3.06e-05 | 105 | 49 | 5 | MM14842 | |
| Pathway | REACTOME_PRE_NOTCH_PROCESSING_IN_GOLGI | 3.10e-05 | 18 | 49 | 3 | M614 | |
| Pathway | KEGG_ARACHIDONIC_ACID_METABOLISM | 4.76e-05 | 58 | 49 | 4 | M5410 | |
| Pathway | WP_TAMOXIFEN_METABOLISM | 5.02e-05 | 21 | 49 | 3 | M39631 | |
| Pathway | WP_NOTCH_SIGNALING_WP61 | 5.81e-05 | 61 | 49 | 4 | M39540 | |
| Pathway | WP_OXIDATION_BY_CYTOCHROME_P450 | 6.20e-05 | 62 | 49 | 4 | M39653 | |
| Pathway | REACTOME_NOTCH_HLH_TRANSCRIPTION_PATHWAY | 6.66e-05 | 23 | 49 | 3 | MM14954 | |
| Pathway | REACTOME_CYTOCHROME_P450_ARRANGED_BY_SUBSTRATE_TYPE | 7.02e-05 | 64 | 49 | 4 | M5650 | |
| Pathway | KEGG_DORSO_VENTRAL_AXIS_FORMATION | 7.59e-05 | 24 | 49 | 3 | M11190 | |
| Pathway | WP_ESTROGEN_METABOLISM_WP5276 | 7.59e-05 | 24 | 49 | 3 | M46445 | |
| Pathway | REACTOME_XENOBIOTICS | 8.60e-05 | 25 | 49 | 3 | MM14846 | |
| Pathway | REACTOME_DISEASES_ASSOCIATED_WITH_O_GLYCOSYLATION_OF_PROTEINS | 8.91e-05 | 68 | 49 | 4 | M27303 | |
| Pathway | REACTOME_BIOLOGICAL_OXIDATIONS | 1.08e-04 | 220 | 49 | 6 | M10320 | |
| Pathway | REACTOME_NOTCH_HLH_TRANSCRIPTION_PATHWAY | 1.22e-04 | 28 | 49 | 3 | M6177 | |
| Pathway | REACTOME_ACTIVATED_NOTCH1_TRANSMITS_SIGNAL_TO_THE_NUCLEUS | 1.66e-04 | 31 | 49 | 3 | M592 | |
| Pathway | BIOCARTA_NOTCH_PATHWAY | 1.76e-04 | 6 | 49 | 2 | MM1584 | |
| Pathway | BIOCARTA_NOTCH_PATHWAY | 1.76e-04 | 6 | 49 | 2 | M22074 | |
| Pathway | REACTOME_BIOSYNTHESIS_OF_MARESIN_LIKE_SPMS | 1.76e-04 | 6 | 49 | 2 | M27909 | |
| Pathway | WP_DELTANOTCH_SIGNALING_PATHWAY | 1.85e-04 | 82 | 49 | 4 | MM15922 | |
| Pathway | KEGG_ECM_RECEPTOR_INTERACTION | 2.03e-04 | 84 | 49 | 4 | M7098 | |
| Pathway | WP_OSX_AND_MIRNAS_IN_TOOTH_DEVELOPMENT | 2.19e-04 | 34 | 49 | 3 | M39390 | |
| Pathway | WP_EPITHELIAL_TO_MESENCHYMAL_TRANSITION_IN_COLORECTAL_CANCER | 2.32e-04 | 161 | 49 | 5 | M39770 | |
| Pathway | WP_ARACHIDONATE_EPOXYGENASE_EPOXIDE_HYDROLASE | 2.46e-04 | 7 | 49 | 2 | M39515 | |
| Pathway | REACTOME_SIGNALING_BY_NOTCH1_T_7_9_NOTCH1_M1580_K2555_TRANSLOCATION_MUTANT | 2.46e-04 | 7 | 49 | 2 | M27199 | |
| Pathway | REACTOME_SYNTHESIS_OF_EPOXY_EET_AND_DIHYDROXYEICOSATRIENOIC_ACIDS_DHET | 2.46e-04 | 7 | 49 | 2 | MM14856 | |
| Pathway | WP_NEOVASCULARIZATION_PROCESSES | 2.82e-04 | 37 | 49 | 3 | M39506 | |
| Pathway | REACTOME_BIOSYNTHESIS_OF_MARESINS | 3.27e-04 | 8 | 49 | 2 | M27891 | |
| Pathway | REACTOME_ABACAVIR_ADME | 3.27e-04 | 8 | 49 | 2 | MM14869 | |
| Pathway | WP_NEURAL_CREST_DIFFERENTIATION | 3.52e-04 | 97 | 49 | 4 | MM15926 | |
| Pathway | WP_NEURAL_CREST_DIFFERENTIATION | 4.11e-04 | 101 | 49 | 4 | M39448 | |
| Pathway | WP_SOMITOGENESIS_IN_THE_CONTEXT_OF_SPONDYLOCOSTAL_DYSOSTOSIS | 4.20e-04 | 9 | 49 | 2 | M39869 | |
| Pathway | WP_EICOSANOID_METABOLISM_VIA_CYTOCHROME_P450_MONOOXYGENASES_PATHWAY | 4.20e-04 | 9 | 49 | 2 | M39819 | |
| Pathway | REACTOME_ASPIRIN_ADME | 4.73e-04 | 44 | 49 | 3 | M45014 | |
| Pathway | WP_FATTY_ACID_OMEGAOXIDATION | 5.23e-04 | 10 | 49 | 2 | MM15833 | |
| Pathway | WP_GENE_REGULATORY_NETWORK_MODELLING_SOMITOGENESIS | 5.23e-04 | 10 | 49 | 2 | MM15839 | |
| Pathway | WP_GENE_REGULATORY_NETWORK_MODELING_SOMITOGENESIS | 6.38e-04 | 11 | 49 | 2 | M39647 | |
| Pathway | PID_INTEGRIN4_PATHWAY | 6.38e-04 | 11 | 49 | 2 | M158 | |
| Pathway | REACTOME_SYNTHESIS_OF_16_20_HYDROXYEICOSATETRAENOIC_ACIDS_HETE | 6.38e-04 | 11 | 49 | 2 | MM14863 | |
| Pathway | REACTOME_ETHANOL_OXIDATION | 6.38e-04 | 11 | 49 | 2 | MM15405 | |
| Pathway | REACTOME_SIGNALING_BY_NOTCH3 | 6.50e-04 | 49 | 49 | 3 | M618 | |
| Pathway | WP_OSTEOBLAST_DIFFERENTIATION_AND_RELATED_DISEASES | 7.39e-04 | 118 | 49 | 4 | M39852 | |
| Pathway | REACTOME_DRUG_ADME | 7.63e-04 | 119 | 49 | 4 | MM15692 | |
| Pathway | BIOCARTA_HES_PATHWAY | 7.64e-04 | 12 | 49 | 2 | MM1562 | |
| Pathway | REACTOME_ETHANOL_OXIDATION | 7.64e-04 | 12 | 49 | 2 | M14663 | |
| Pathway | BIOCARTA_HES_PATHWAY | 7.64e-04 | 12 | 49 | 2 | M22042 | |
| Pathway | REACTOME_CYP2E1_REACTIONS | 7.64e-04 | 12 | 49 | 2 | MM14847 | |
| Pathway | REACTOME_BIOSYNTHESIS_OF_MARESINS | 7.64e-04 | 12 | 49 | 2 | MM15616 | |
| Pathway | REACTOME_BIOLOGICAL_OXIDATIONS | 9.45e-04 | 219 | 49 | 5 | MM14838 | |
| Pathway | BIOCARTA_PS1_PATHWAY | 1.05e-03 | 14 | 49 | 2 | MM1459 | |
| Pathway | BIOCARTA_PS1_PATHWAY | 1.05e-03 | 14 | 49 | 2 | M16173 | |
| Pathway | REACTOME_ARACHIDONIC_ACID_METABOLISM | 1.12e-03 | 59 | 49 | 3 | M27140 | |
| Pathway | REACTOME_SIGNALING_BY_NOTCH1_HD_DOMAIN_MUTANTS_IN_CANCER | 1.21e-03 | 15 | 49 | 2 | M27202 | |
| Pathway | WP_FATTY_ACID_OMEGAOXIDATION | 1.21e-03 | 15 | 49 | 2 | M39717 | |
| Pathway | REACTOME_DEGRADATION_OF_THE_EXTRACELLULAR_MATRIX | 1.40e-03 | 140 | 49 | 4 | M587 | |
| Pathway | REACTOME_DISEASES_OF_GLYCOSYLATION | 1.51e-03 | 143 | 49 | 4 | M27275 | |
| Pathway | REACTOME_CYTOCHROME_P450_ARRANGED_BY_SUBSTRATE_TYPE | 1.55e-03 | 66 | 49 | 3 | MM14839 | |
| Pathway | PID_INTEGRIN1_PATHWAY | 1.55e-03 | 66 | 49 | 3 | M18 | |
| Pathway | WP_NOTCH1_REGULATION_OF_ENDOTHELIAL_CELL_CALCIFICATION | 1.56e-03 | 17 | 49 | 2 | M39389 | |
| Pathway | REACTOME_SIGNALING_BY_NOTCH | 1.58e-03 | 246 | 49 | 5 | M10189 | |
| Pathway | REACTOME_BIOSYNTHESIS_OF_SPECIALIZED_PRORESOLVING_MEDIATORS_SPMS | 1.95e-03 | 19 | 49 | 2 | M27889 | |
| Pathway | REACTOME_SIGNALING_BY_NOTCH3 | 1.95e-03 | 19 | 49 | 2 | MM15594 | |
| Pathway | WP_BREAST_CANCER_PATHWAY | 1.98e-03 | 154 | 49 | 4 | M39739 | |
| Pathway | REACTOME_SIGNALING_BY_NOTCH1 | 2.15e-03 | 74 | 49 | 3 | M616 | |
| Pathway | REACTOME_NOTCH4_INTRACELLULAR_DOMAIN_REGULATES_TRANSCRIPTION | 2.16e-03 | 20 | 49 | 2 | M27881 | |
| Pathway | REACTOME_METAL_ION_SLC_TRANSPORTERS | 2.16e-03 | 20 | 49 | 2 | MM15077 | |
| Pathway | REACTOME_ECM_PROTEOGLYCANS | 2.32e-03 | 76 | 49 | 3 | M27219 | |
| Pathway | REACTOME_INTEGRIN_CELL_SURFACE_INTERACTIONS | 2.32e-03 | 76 | 49 | 3 | MM14867 | |
| Pathway | REACTOME_BIOSYNTHESIS_OF_SPECIALIZED_PRORESOLVING_MEDIATORS_SPMS | 2.62e-03 | 22 | 49 | 2 | MM15614 | |
| Pathway | REACTOME_METAL_ION_SLC_TRANSPORTERS | 3.11e-03 | 24 | 49 | 2 | M18795 | |
| Pathway | REACTOME_INTEGRIN_CELL_SURFACE_INTERACTIONS | 3.19e-03 | 85 | 49 | 3 | M16441 | |
| Pathway | REACTOME_NOTCH3_INTRACELLULAR_DOMAIN_REGULATES_TRANSCRIPTION | 3.37e-03 | 25 | 49 | 2 | M27880 | |
| Pubmed | Biochemistry and molecular biology of the human CYP2C subfamily. | 1.79e-11 | 4 | 73 | 4 | 7704034 | |
| Pubmed | 1.79e-11 | 4 | 73 | 4 | 19706858 | ||
| Pubmed | 1.79e-11 | 4 | 73 | 4 | 2009263 | ||
| Pubmed | 1.79e-11 | 4 | 73 | 4 | 21798861 | ||
| Pubmed | 1.79e-11 | 4 | 73 | 4 | 23755828 | ||
| Pubmed | 8.91e-11 | 5 | 73 | 4 | 20554499 | ||
| Pubmed | Segmental expression of Notch and Hairy genes in nephrogenesis. | 2.15e-10 | 17 | 73 | 5 | 15821257 | |
| Pubmed | 6.22e-10 | 7 | 73 | 4 | 10079256 | ||
| Pubmed | The distribution of Notch receptors and their ligands during articular cartilage development. | 6.22e-10 | 7 | 73 | 4 | 12846471 | |
| Pubmed | 1.24e-09 | 8 | 73 | 4 | 9858718 | ||
| Pubmed | 2.23e-09 | 9 | 73 | 4 | 12122015 | ||
| Pubmed | 2.23e-09 | 9 | 73 | 4 | 11118901 | ||
| Pubmed | 2.23e-09 | 9 | 73 | 4 | 16245338 | ||
| Pubmed | Adamts18 modulates the development of the aortic arch and common carotid artery. | 2.25e-09 | 26 | 73 | 5 | 34189436 | |
| Pubmed | Notch signaling prevents mucous metaplasia in mouse conducting airways during postnatal development. | 2.76e-09 | 27 | 73 | 5 | 21791528 | |
| Pubmed | 3.56e-09 | 175 | 73 | 8 | 28071719 | ||
| Pubmed | Spatiotemporal expression of Notch receptors and ligands in developing mouse placenta. | 3.71e-09 | 10 | 73 | 4 | 23665443 | |
| Pubmed | Notch signaling in stomach epithelial stem cell homeostasis. | 4.05e-09 | 29 | 73 | 5 | 21402740 | |
| Pubmed | A family of mammalian Fringe genes implicated in boundary determination and the Notch pathway. | 5.83e-09 | 11 | 73 | 4 | 9187150 | |
| Pubmed | Coexpression of Cux-1 and Notch signaling pathway components during kidney development. | 5.83e-09 | 11 | 73 | 4 | 15499562 | |
| Pubmed | 5.83e-09 | 11 | 73 | 4 | 10878608 | ||
| Pubmed | 5.83e-09 | 11 | 73 | 4 | 12866128 | ||
| Pubmed | 8.73e-09 | 12 | 73 | 4 | 15465494 | ||
| Pubmed | 8.73e-09 | 12 | 73 | 4 | 10952889 | ||
| Pubmed | The human CYP2C locus: a prototype for intergenic and exon repetition splicing events. | 8.87e-09 | 3 | 73 | 3 | 10704292 | |
| Pubmed | Notch receptor expression in human brain arteriovenous malformations. | 8.87e-09 | 3 | 73 | 3 | 25846406 | |
| Pubmed | 8.87e-09 | 3 | 73 | 3 | 35134542 | ||
| Pubmed | Distribution of CYP2C polymorphisms in an Amerindian population of Brazil. | 8.87e-09 | 3 | 73 | 3 | 21977947 | |
| Pubmed | 8.87e-09 | 3 | 73 | 3 | 23118231 | ||
| Pubmed | 8.87e-09 | 3 | 73 | 3 | 28687336 | ||
| Pubmed | A 2.4-megabase physical map spanning the CYP2C gene cluster on chromosome 10q24. | 8.87e-09 | 3 | 73 | 3 | 8530044 | |
| Pubmed | 8.87e-09 | 3 | 73 | 3 | 21173785 | ||
| Pubmed | 8.87e-09 | 3 | 73 | 3 | 15102943 | ||
| Pubmed | 8.87e-09 | 3 | 73 | 3 | 24430292 | ||
| Pubmed | 8.87e-09 | 3 | 73 | 3 | 20665013 | ||
| Pubmed | 8.87e-09 | 3 | 73 | 3 | 27803446 | ||
| Pubmed | Characterisation of CYP2C8, CYP2C9 and CYP2C19 polymorphisms in a Ghanaian population. | 8.87e-09 | 3 | 73 | 3 | 19954515 | |
| Pubmed | 8.87e-09 | 3 | 73 | 3 | 8095407 | ||
| Pubmed | Vascular expression of Notch pathway receptors and ligands is restricted to arterial vessels. | 1.26e-08 | 13 | 73 | 4 | 11578869 | |
| Pubmed | Inhibition of notch1-dependent cardiomyogenesis leads to a dilated myopathy in the neonatal heart. | 1.26e-08 | 13 | 73 | 4 | 20558824 | |
| Pubmed | Novel DNA sequence variations of cytochrome P450 genes in the Han Chinese population. | 1.76e-08 | 14 | 73 | 4 | 19290787 | |
| Pubmed | 1.76e-08 | 14 | 73 | 4 | 28192800 | ||
| Pubmed | 1.76e-08 | 14 | 73 | 4 | 14757642 | ||
| Pubmed | 2.40e-08 | 15 | 73 | 4 | 12971992 | ||
| Pubmed | 2.50e-08 | 41 | 73 | 5 | 22675208 | ||
| Pubmed | Expression of Notch pathway components in fetal and adult mouse small intestine. | 3.19e-08 | 16 | 73 | 4 | 12617809 | |
| Pubmed | 3.19e-08 | 16 | 73 | 4 | 17273555 | ||
| Pubmed | Requirement of Math1 for secretory cell lineage commitment in the mouse intestine. | 3.19e-08 | 16 | 73 | 4 | 11739954 | |
| Pubmed | 3.19e-08 | 16 | 73 | 4 | 10842072 | ||
| Pubmed | Association of warfarin dose with genes involved in its action and metabolism. | 3.19e-08 | 16 | 73 | 4 | 17048007 | |
| Pubmed | 3.54e-08 | 4 | 73 | 3 | 24145721 | ||
| Pubmed | 3.54e-08 | 4 | 73 | 3 | 20069356 | ||
| Pubmed | Expression and clinical significance of Notch receptors in human renal cell carcinoma. | 3.54e-08 | 4 | 73 | 3 | 19404845 | |
| Pubmed | 3.54e-08 | 4 | 73 | 3 | 28669409 | ||
| Pubmed | 3.54e-08 | 4 | 73 | 3 | 11401408 | ||
| Pubmed | Functional conservation of mouse Notch receptor family members. | 3.54e-08 | 4 | 73 | 3 | 8898100 | |
| Pubmed | 3.54e-08 | 4 | 73 | 3 | 28990182 | ||
| Pubmed | 3.54e-08 | 4 | 73 | 3 | 23444212 | ||
| Pubmed | Deregulated expression of Notch receptors in human hepatocellular carcinoma. | 3.54e-08 | 4 | 73 | 3 | 17920003 | |
| Pubmed | Analysis of HeyL expression in wild-type and Notch pathway mutant mouse embryos. | 3.54e-08 | 4 | 73 | 3 | 11044625 | |
| Pubmed | Prognostic roles of mRNA expression of notch receptors in non-small cell lung cancer. | 3.54e-08 | 4 | 73 | 3 | 28061457 | |
| Pubmed | 3.54e-08 | 4 | 73 | 3 | 11466531 | ||
| Pubmed | 3.54e-08 | 4 | 73 | 3 | 24151014 | ||
| Pubmed | Polymorphism of CYP2D6, CYP2C19, CYP2C9 and CYP2C8 in the Faroese population. | 3.54e-08 | 4 | 73 | 3 | 16025294 | |
| Pubmed | Notch as a mediator of cell fate determination in hematopoiesis: evidence and speculation. | 3.54e-08 | 4 | 73 | 3 | 10194420 | |
| Pubmed | 3.54e-08 | 4 | 73 | 3 | 11459941 | ||
| Pubmed | Mutational analysis of NOTCH1, 2, 3 and 4 genes in common solid cancers and acute leukemias. | 3.54e-08 | 4 | 73 | 3 | 18184405 | |
| Pubmed | Notch signaling in the mammalian central nervous system: insights from mouse mutants. | 3.54e-08 | 4 | 73 | 3 | 15917835 | |
| Pubmed | 4.16e-08 | 17 | 73 | 4 | 18694942 | ||
| Pubmed | 4.16e-08 | 17 | 73 | 4 | 39315665 | ||
| Pubmed | 5.34e-08 | 18 | 73 | 4 | 18093989 | ||
| Pubmed | ADAMTS18-fibronectin interaction regulates the morphology of liver sinusoidal endothelial cells. | 5.34e-08 | 18 | 73 | 4 | 39040056 | |
| Pubmed | 5.34e-08 | 18 | 73 | 4 | 15689374 | ||
| Pubmed | 6.76e-08 | 19 | 73 | 4 | 16518823 | ||
| Pubmed | 8.43e-08 | 20 | 73 | 4 | 20437850 | ||
| Pubmed | Molecular genetics of the human cytochrome P450 monooxygenase superfamily. | 8.43e-08 | 20 | 73 | 4 | 9890157 | |
| Pubmed | 8.84e-08 | 5 | 73 | 3 | 19415824 | ||
| Pubmed | 8.84e-08 | 5 | 73 | 3 | 11101851 | ||
| Pubmed | Expression patterns of Notch receptors and their ligands Jagged and Delta in human placenta. | 8.84e-08 | 5 | 73 | 3 | 21726900 | |
| Pubmed | Prevalence of CYP450 gene variations in patients with type 2 diabetes. | 8.84e-08 | 5 | 73 | 3 | 20857895 | |
| Pubmed | Physical interaction of Delta1, Jagged1, and Jagged2 with Notch1 and Notch3 receptors. | 8.84e-08 | 5 | 73 | 3 | 11006133 | |
| Pubmed | 8.84e-08 | 5 | 73 | 3 | 21124806 | ||
| Pubmed | 8.84e-08 | 5 | 73 | 3 | 23675950 | ||
| Pubmed | 8.84e-08 | 5 | 73 | 3 | 21602525 | ||
| Pubmed | 8.84e-08 | 5 | 73 | 3 | 15882997 | ||
| Pubmed | 1.04e-07 | 21 | 73 | 4 | 28656980 | ||
| Pubmed | 1.27e-07 | 22 | 73 | 4 | 34998785 | ||
| Pubmed | 1.53e-07 | 23 | 73 | 4 | 14701881 | ||
| Pubmed | 1.53e-07 | 23 | 73 | 4 | 36239412 | ||
| Pubmed | 1.77e-07 | 6 | 73 | 3 | 9111338 | ||
| Pubmed | 1.77e-07 | 6 | 73 | 3 | 10958687 | ||
| Pubmed | Characterization of Notch receptor expression in the developing mammalian heart and liver. | 1.77e-07 | 6 | 73 | 3 | 12244553 | |
| Pubmed | 1.77e-07 | 6 | 73 | 3 | 7835890 | ||
| Pubmed | 1.77e-07 | 6 | 73 | 3 | 18299578 | ||
| Pubmed | Genetic polymorphism of cytochrome P450s and P-glycoprotein in the Finnish population. | 1.77e-07 | 6 | 73 | 3 | 17635176 | |
| Pubmed | 1.77e-07 | 6 | 73 | 3 | 9882480 | ||
| Pubmed | Cloning and functional characterization of the murine mastermind-like 1 (Maml1) gene. | 1.77e-07 | 6 | 73 | 3 | 15019995 | |
| Pubmed | Notch controls the magnitude of T helper cell responses by promoting cellular longevity. | 1.77e-07 | 6 | 73 | 3 | 22615412 | |
| Pubmed | 1.77e-07 | 6 | 73 | 3 | 20870902 | ||
| Pubmed | 1.77e-07 | 6 | 73 | 3 | 17822320 | ||
| Interaction | MFAP5 interactions | 6.48e-10 | 52 | 72 | 7 | int:MFAP5 | |
| Interaction | HOXA1 interactions | FBN1 VWF MEGF6 DBF4B KPRP LAMA5 PLSCR2 ODF1 TEKT5 NOTCH1 NOTCH3 KRTAP12-4 | 4.55e-09 | 356 | 72 | 12 | int:HOXA1 |
| Interaction | IGFL3 interactions | 9.02e-09 | 75 | 72 | 7 | int:IGFL3 | |
| Interaction | NTN5 interactions | 2.04e-08 | 24 | 72 | 5 | int:NTN5 | |
| Interaction | CYP2C19 interactions | 4.35e-07 | 5 | 72 | 3 | int:CYP2C19 | |
| Interaction | MAML3 interactions | 6.95e-07 | 20 | 72 | 4 | int:MAML3 | |
| Interaction | ZFP41 interactions | 1.83e-06 | 57 | 72 | 5 | int:ZFP41 | |
| Interaction | CYP2C18 interactions | 2.47e-06 | 27 | 72 | 4 | int:CYP2C18 | |
| Interaction | NOTCH2 interactions | 1.92e-05 | 423 | 72 | 9 | int:NOTCH2 | |
| Interaction | MAML2 interactions | 2.87e-05 | 17 | 72 | 3 | int:MAML2 | |
| Interaction | ADH1C interactions | 4.07e-05 | 19 | 72 | 3 | int:ADH1C | |
| Interaction | ZNF224 interactions | 4.77e-05 | 20 | 72 | 3 | int:ZNF224 | |
| Interaction | NOTCH3 interactions | 5.26e-05 | 113 | 72 | 5 | int:NOTCH3 | |
| Interaction | VIP interactions | 7.36e-05 | 23 | 72 | 3 | int:VIP | |
| Interaction | CACNA1A interactions | 7.88e-05 | 123 | 72 | 5 | int:CACNA1A | |
| Interaction | ZDHHC15 interactions | 8.50e-05 | 125 | 72 | 5 | int:ZDHHC15 | |
| Interaction | FBLN2 interactions | 9.13e-05 | 66 | 72 | 4 | int:FBLN2 | |
| Interaction | FBXO2 interactions | 1.07e-04 | 411 | 72 | 8 | int:FBXO2 | |
| Interaction | PSEN1 interactions | 1.61e-04 | 227 | 72 | 6 | int:PSEN1 | |
| Interaction | EGFL7 interactions | 1.66e-04 | 77 | 72 | 4 | int:EGFL7 | |
| Interaction | ZNF408 interactions | 1.71e-04 | 145 | 72 | 5 | int:ZNF408 | |
| Interaction | KRTAP19-6 interactions | 1.84e-04 | 79 | 72 | 4 | int:KRTAP19-6 | |
| Interaction | DLL4 interactions | 1.87e-04 | 6 | 72 | 2 | int:DLL4 | |
| Interaction | OTX1 interactions | 2.33e-04 | 155 | 72 | 5 | int:OTX1 | |
| Interaction | PSEN2 interactions | 2.55e-04 | 86 | 72 | 4 | int:PSEN2 | |
| Interaction | DLK2 interactions | 2.87e-04 | 36 | 72 | 3 | int:DLK2 | |
| Interaction | ADGRE5 interactions | 2.94e-04 | 163 | 72 | 5 | int:ADGRE5 | |
| Interaction | DLL1 interactions | 3.37e-04 | 38 | 72 | 3 | int:DLL1 | |
| Interaction | APOE interactions | 3.67e-04 | 171 | 72 | 5 | int:APOE | |
| Interaction | POFUT1 interactions | 4.87e-04 | 43 | 72 | 3 | int:POFUT1 | |
| Cytoband | 10q24 | 2.43e-05 | 35 | 73 | 3 | 10q24 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr10q23 | 2.73e-04 | 195 | 73 | 4 | chr10q23 | |
| Cytoband | 4q23 | 4.65e-04 | 20 | 73 | 2 | 4q23 | |
| Cytoband | 3q24 | 1.13e-03 | 31 | 73 | 2 | 3q24 | |
| Cytoband | 21q22.3 | 1.14e-03 | 128 | 73 | 3 | 21q22.3 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr4q23 | 1.60e-03 | 37 | 73 | 2 | chr4q23 | |
| Cytoband | 1q23.1 | 2.47e-03 | 46 | 73 | 2 | 1q23.1 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr3q24 | 2.57e-03 | 47 | 73 | 2 | chr3q24 | |
| GeneFamily | Cytochrome P450 family 2 | 2.98e-06 | 35 | 52 | 4 | 1001 | |
| GeneFamily | Phospholipid scramblases | 8.07e-05 | 5 | 52 | 2 | 954 | |
| GeneFamily | Alcohol dehydrogenases | 2.25e-04 | 8 | 52 | 2 | 397 | |
| GeneFamily | Laminin subunits | 5.26e-04 | 12 | 52 | 2 | 626 | |
| GeneFamily | Low density lipoprotein receptors | 6.20e-04 | 13 | 52 | 2 | 634 | |
| GeneFamily | Zinc fingers C2H2-type|ZF class homeoboxes and pseudogenes | 4.27e-03 | 718 | 52 | 7 | 28 | |
| GeneFamily | Blood group antigens|CD molecules|I-set domain containing|Immunoglobulin like domain containing | 1.11e-02 | 161 | 52 | 3 | 593 | |
| Coexpression | NABA_ECM_GLYCOPROTEINS | 1.56e-10 | 196 | 72 | 10 | M3008 | |
| Coexpression | NABA_CORE_MATRISOME | 2.38e-10 | 275 | 72 | 11 | M5884 | |
| Coexpression | NABA_ECM_GLYCOPROTEINS | 5.52e-08 | 191 | 72 | 8 | MM17059 | |
| Coexpression | NABA_CORE_MATRISOME | 5.52e-08 | 270 | 72 | 9 | MM17057 | |
| Coexpression | FUKUSHIMA_TNFSF11_TARGETS | 9.29e-08 | 16 | 72 | 4 | MM1296 | |
| Coexpression | FUKUSHIMA_TNFSF11_TARGETS | 9.29e-08 | 16 | 72 | 4 | M2207 | |
| Coexpression | NABA_MATRISOME | EYS SCUBE1 FBN1 FBN2 VWF PXDN COMP CRIM1 MEGF6 PXDNL COL28A1 LAMA1 LAMA5 MUC5AC | 6.52e-07 | 1026 | 72 | 14 | M5889 |
| Coexpression | GAO_LARGE_INTESTINE_ADULT_CJ_IMMUNE_CELLS | 1.19e-06 | 505 | 72 | 10 | M39167 | |
| Coexpression | PILON_KLF1_TARGETS_UP | WDR19 CYP2C19 CYP2C9 FBN2 VWF PXDN DLK1 DLL1 SLC30A1 SLC30A10 | 2.20e-06 | 541 | 72 | 10 | MM1061 |
| Coexpression | NABA_MATRISOME | SCUBE1 FBN1 FBN2 VWF PXDN COMP CRIM1 MEGF6 COL28A1 LAMA1 LAMA5 MUC5AC | 1.79e-05 | 1008 | 72 | 12 | MM17056 |
| Coexpression | SAENZ_DETOX_PATHWAY_AND_CARCINOGENESIS_DN | 2.19e-05 | 20 | 72 | 3 | MM1104 | |
| Coexpression | TUOMISTO_TUMOR_SUPPRESSION_BY_COL13A1_DN | 3.86e-05 | 24 | 72 | 3 | MM708 | |
| Coexpression | GSE6090_UNSTIM_VS_DC_SIGN_STIM_DC_DN | 5.19e-05 | 146 | 72 | 5 | M6812 | |
| Coexpression | PILON_KLF1_TARGETS_UP | 7.10e-05 | 503 | 72 | 8 | M2226 | |
| Coexpression | WENG_POR_DOSAGE | 7.65e-05 | 30 | 72 | 3 | MM1199 | |
| Coexpression | HU_FETAL_RETINA_FIBROBLAST | 9.06e-05 | 385 | 72 | 7 | M39264 | |
| Coexpression | HALLMARK_NOTCH_SIGNALING | 9.31e-05 | 32 | 72 | 3 | M5903 | |
| Coexpression | GAUSSMANN_MLL_AF4_FUSION_TARGETS_G_UP | 9.40e-05 | 267 | 72 | 6 | MM984 | |
| Coexpression | RICKMAN_HEAD_AND_NECK_CANCER_E | 9.81e-05 | 87 | 72 | 4 | M19837 | |
| Coexpression | JONES_OVARY_NK_CELL | 1.07e-04 | 89 | 72 | 4 | M48353 | |
| Coexpression | WIEMANN_TELOMERE_SHORTENING_AND_CHRONIC_LIVER_DAMAGE_DN | 1.11e-04 | 6 | 72 | 2 | MM971 | |
| Coexpression | AIZARANI_LIVER_C17_HEPATOCYTES_3 | 1.81e-04 | 102 | 72 | 4 | M39119 | |
| Coexpression | MIKKELSEN_MCV6_HCP_WITH_H3K27ME3 | 2.01e-04 | 438 | 72 | 7 | M1954 | |
| Coexpression | MIKKELSEN_MCV6_HCP_WITH_H3K27ME3 | 2.06e-04 | 440 | 72 | 7 | MM832 | |
| Coexpression | FAN_EMBRYONIC_CTX_BRAIN_ENDOTHELIAL_1 | 2.06e-04 | 440 | 72 | 7 | M39039 | |
| Coexpression | HALLMARK_WNT_BETA_CATENIN_SIGNALING | 2.11e-04 | 42 | 72 | 3 | M5895 | |
| Coexpression | HALLMARK_EPITHELIAL_MESENCHYMAL_TRANSITION | 2.27e-04 | 200 | 72 | 5 | M5930 | |
| Coexpression | MARTINEZ_RB1_TARGETS_DN | 3.30e-04 | 630 | 72 | 8 | MM1038 | |
| CoexpressionAtlas | Stromal Cells, St.31-38-44-.SLN, CD45- gp38- CD31- CD44-, Lymph Node, avg-2 | 1.21e-05 | 453 | 67 | 9 | GSM777067_500 | |
| CoexpressionAtlas | dev gonad_e13.5_F_VascAssocMesenchStromOvary_MafB_k-means-cluster#3_top-relative-expression-ranked_500 | 4.19e-05 | 122 | 67 | 5 | gudmap_dev gonad_e13.5_F_VascAssocMesenchStromOvary_MafB_k3_500 | |
| CoexpressionAtlas | liver | 5.07e-05 | 419 | 67 | 8 | liver | |
| CoexpressionAtlas | kidney_P0_JuxtaGlom_Ren1_top-relative-expression-ranked_500 | 9.15e-05 | 456 | 67 | 8 | gudmap_kidney_P0_JuxtaGlom_Ren1_500 | |
| CoexpressionAtlas | Stromal Cells, BEC.SLN, gp38- CD31+, Lymph Node, avg-4 | 9.57e-05 | 459 | 67 | 8 | GSM777037_500 | |
| CoexpressionAtlas | dev gonad_e12.5_F_VasAssMesen_MafB_k-means-cluster#4_top-relative-expression-ranked_500 | 9.83e-05 | 146 | 67 | 5 | gudmap_dev gonad_e12.5_F_VasAssMesen_MafB_k4_500 | |
| CoexpressionAtlas | dev gonad_e13.5_M_InterstitFLeydig_MafB_top-relative-expression-ranked_500 | 1.29e-04 | 356 | 67 | 7 | gudmap_dev gonad_e13.5_M_InterstitFLeydig_MafB_500 | |
| CoexpressionAtlas | kidney_P4_CapMesRenVes_Crym_top-relative-expression-ranked_1000 | 1.62e-04 | 783 | 67 | 10 | gudmap_kidney_P4_CapMesRenVes_Crym_1000 | |
| CoexpressionAtlas | dev gonad_e13.5_F_VascAssocMesenchStromOvary_MafB_k-means-cluster#2_top-relative-expression-ranked_1000 | 1.88e-04 | 265 | 67 | 6 | gudmap_dev gonad_e13.5_F_VascAssocMesenchStromOvary_MafB_k2_1000 | |
| ToppCell | facs-Liver-Non-hepatocytes-24m-Endothelial-endothelial_cell_of_hepatic_sinusoid|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.97e-08 | 192 | 73 | 7 | 2bfac6b3956265205ca47d06888851ed68b65999 | |
| ToppCell | facs-Liver-Non-hepatocytes-24m-Endothelial|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.97e-08 | 192 | 73 | 7 | d525f7f088a53110912600a7c9f6d33b9270d534 | |
| ToppCell | COVID-19-Endothelial_cells-Inflamed_endothelial_cells|COVID-19 / group, cell type (main and fine annotations) | 3.07e-08 | 193 | 73 | 7 | 979ebefa527f86bebeea5d94e626ee6c1cc7d53b | |
| ToppCell | facs-Liver-Non-hepatocytes-24m-Endothelial-endothelial_cell_of_hepatic_sinusoid|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.18e-08 | 194 | 73 | 7 | c8b9551b93a5aed62154b487db90130604a6125c | |
| ToppCell | facs-Heart-RA-18m-Endothelial|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.30e-08 | 195 | 73 | 7 | 30c75761079fa1e1a3b84d23c88a222f459d5ce5 | |
| ToppCell | PND28-Endothelial-Endothelial_blood-vessel-Macrovascular_EC-VEC-VEC_mature|PND28 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 3.94e-07 | 172 | 73 | 6 | fc092a0631555d79e00ef9890cbd806e15bca2d4 | |
| ToppCell | PND28-Endothelial-Endothelial_blood-vessel-Macrovascular_EC-VEC|PND28 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 3.94e-07 | 172 | 73 | 6 | 745725bd10c82017d678463b8fef0d2dcf09a8fd | |
| ToppCell | COVID-19-Endothelial_cells-Endothelial_cells_(other)|COVID-19 / group, cell type (main and fine annotations) | 5.31e-07 | 181 | 73 | 6 | 26eb4ee57a70dbf54e096b73129fda9dfda1f6ec | |
| ToppCell | Primary_Visual_cortex_(V1C)-Non-neuronal-Mesenchymal-Mes-Pericyte|Primary_Visual_cortex_(V1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 5.31e-07 | 181 | 73 | 6 | 634a4f4e5942473e60d08d0b0936407b04bc6b7c | |
| ToppCell | Primary_Visual_cortex_(V1C)-Non-neuronal-Mesenchymal-Mes-Pericyte-Peri_L1-6_MUSTN1|Primary_Visual_cortex_(V1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 5.31e-07 | 181 | 73 | 6 | c2938cf1f5d4875be07a56a1f36c94f8eab37d99 | |
| ToppCell | droplet-Heart-HEART_(LV+RV_ONLY)-30m-Mesenchymal-coronary_vascular_endothelial_cell|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.23e-07 | 186 | 73 | 6 | 4ae3c0fe8640a8d029875cf3f0f5ffbba38e85f8 | |
| ToppCell | facs-Heart-RA-3m-Endothelial-endocardial_cell|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.63e-07 | 188 | 73 | 6 | 4ddb11a90bf3baa7237bde304db44dfcc56aed52 | |
| ToppCell | facs-Heart-RA-3m-Endothelial-endothelial_cell_of_endocardium|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.63e-07 | 188 | 73 | 6 | e47e66906922d5c69b1aafe28face0787d3fc563 | |
| ToppCell | PND01-Endothelial-Endothelial_blood-vessel-Macrovascular_EC|PND01 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 6.84e-07 | 189 | 73 | 6 | 1e1afa66b32ae752c0a42b02b80f10205464569c | |
| ToppCell | facs-Heart-LA-24m-Endothelial|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.05e-07 | 190 | 73 | 6 | 911b93c4c828ef2d867b91a5eced2dc12a1baf27 | |
| ToppCell | facs-Limb_Muscle-ForelimbandHindlimb-3m-Endothelial-endothelial_cell|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.05e-07 | 190 | 73 | 6 | 38a815abf0ac5cac6071737cadc54a514f62d37d | |
| ToppCell | facs-Limb_Muscle-ForelimbandHindlimb-3m-Endothelial|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.05e-07 | 190 | 73 | 6 | bb1476b44dd49e1dd52a636a91c4600b6d4fbe2e | |
| ToppCell | facs-Limb_Muscle-ForelimbandHindlimb-3m-Endothelial-nan|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.05e-07 | 190 | 73 | 6 | d180205c70b5ca9bc5a01a2e6cb42fcebc7f630d | |
| ToppCell | droplet-Liver-HEPATOCYTES-1m-Endothelial-endothelial_cell_of_hepatic_sinusoid|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.50e-07 | 192 | 73 | 6 | 5890076929598e88fe9d59a4e4e858b446746ce9 | |
| ToppCell | facs-MAT-Fat-24m-Endothelial-nan|MAT / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.73e-07 | 193 | 73 | 6 | ba9a47e2dc01efa6d2a99b1631d4951fac2648d4 | |
| ToppCell | facs-MAT-Fat-24m-Endothelial-endothelial_cell|MAT / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.73e-07 | 193 | 73 | 6 | 724bb613fa434add5b1c5586b629328f819fbdfe | |
| ToppCell | facs-MAT-Fat-24m-Endothelial|MAT / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.73e-07 | 193 | 73 | 6 | 737e540c72a3cfe8dbd4c0f139f7d729a166793a | |
| ToppCell | facs-Heart-LA-3m-Endothelial|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.96e-07 | 194 | 73 | 6 | 33cc4f1d716cb71d54cdedbe9bbdc0d7b17c4777 | |
| ToppCell | droplet-Fat-Mat-18m-Endothelial-Cd36+|Fat / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.96e-07 | 194 | 73 | 6 | 74d0eaa76f6d9af14110dfe5b4bf9751b99ff6e3 | |
| ToppCell | facs-Liver-Liver_non-hepato/SCs_st-18m-Endothelial-endothelial_cell_of_hepatic_sinusoid|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 8.21e-07 | 195 | 73 | 6 | 12ba6d95e42d06b1991b011043c0e3370a7b4131 | |
| ToppCell | Tracheal-10x5prime-Stromal-Peri/Epineurial_|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 8.71e-07 | 197 | 73 | 6 | 2cb1f557ce1400398975de94638126b4522567f3 | |
| ToppCell | 10x_3'_v2v3-Non-neoplastic-Vascular-Mural_cell-Scavenging_endothelial|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 9.24e-07 | 199 | 73 | 6 | d95d78b2ebc9a20532466e4d4be579b4faf6776f | |
| ToppCell | 10x_3'_v2v3-Non-neoplastic-Vascular-Mural_cell-Scavenging_endothelial-F|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 9.24e-07 | 199 | 73 | 6 | cdcfca94baba66e213cc3ffb0cfb4c75d6ab44ec | |
| ToppCell | Tracheal-NucSeq-Stromal-Peri/Epineurial_|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 9.24e-07 | 199 | 73 | 6 | 3835452e4848d7f7dd8651c17b746b271ef39688 | |
| ToppCell | Tracheal-NucSeq-Stromal-Peri/Epineurial_-NAF_epineurial|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 9.24e-07 | 199 | 73 | 6 | 9c2db0bb94cba71a3cc1827844da090e213e0258 | |
| ToppCell | Striatum-Neuronal-Inhibitory-iN2(Gad1Gad2)-Inhibitory_Neuron.Gad1Gad2.Pnoc_(Fast-spiking_interneuron,_Pvalb+/Pnoc+)-|Striatum / BrainAtlas - Mouse McCarroll V32 | 1.05e-06 | 110 | 73 | 5 | 5496c92932195386025254b9129d69b12c8e3340 | |
| ToppCell | Striatum-Neuronal-Inhibitory-iN2(Gad1Gad2)-Inhibitory_Neuron.Gad1Gad2.Pnoc_(Fast-spiking_interneuron,_Pvalb+/Pnoc+)--|Striatum / BrainAtlas - Mouse McCarroll V32 | 1.05e-06 | 110 | 73 | 5 | 41306a2d4a5a39569437eb123e47f98ef8afab24 | |
| ToppCell | Striatum-Neuronal-Inhibitory-iN2(Gad1Gad2)-Inhibitory_Neuron.Gad1Gad2.Pnoc_(Fast-spiking_interneuron,_Pvalb+/Pnoc+)|Striatum / BrainAtlas - Mouse McCarroll V32 | 1.05e-06 | 110 | 73 | 5 | 1fe08060248b25329f73b80d74435c108bee1359 | |
| ToppCell | TCGA-Bile_Duct|World / Sample_Type by Project: Shred V9 | 3.44e-06 | 140 | 73 | 5 | ca8a0ccbc2f501b759864fe9bb06dc8b44b6b31f | |
| ToppCell | Severe-B_naive-8|World / disease group and sub_cluster of B and Plasma cells(res = 0.5) | 4.08e-06 | 145 | 73 | 5 | a24cad86509208bc7267b02ef1d1b0a25a2a7043 | |
| ToppCell | Somatosensory_Cortex_(S1)-Neuronal-Inh_GABAergic-i_Gaba_2-GABA_VIP_1-Inh_L1-3_VIP_ACHE|Somatosensory_Cortex_(S1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 6.60e-06 | 160 | 73 | 5 | 903727c14e370e5705394240f0ef61fe3e0a4c25 | |
| ToppCell | PND14-Endothelial-Endothelial_blood-vessel-Macrovascular_EC-AEC|PND14 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 7.89e-06 | 166 | 73 | 5 | 7a45785a40b7425f97be67bab1c5ceb69b2bd85a | |
| ToppCell | PND14-Endothelial-Endothelial_blood-vessel-Macrovascular_EC-AEC-AEC_mature|PND14 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 7.89e-06 | 166 | 73 | 5 | bbd382812f8a84a5d99888de2d7cca3a8b5e4695 | |
| ToppCell | facs-Heart-RA-18m-Endothelial-endothelial_cell_of_endocardium|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 8.37e-06 | 168 | 73 | 5 | 06dc5b2d356d3a9454b10bba6f3b9ead2a0a7d46 | |
| ToppCell | facs-Heart-RA-18m-Endothelial-endocardial_cell|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 8.37e-06 | 168 | 73 | 5 | 1002f058a340763e3d8de0bd1f0547a903526ec6 | |
| ToppCell | droplet-Heart-4Chambers-18m-Endothelial|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 9.64e-06 | 173 | 73 | 5 | 9a04271c51fae34f547db3206f9ff5857686e45c | |
| ToppCell | PND01-03-samps-Endothelial-Postnatal_endothelial-endothelial_cells_D|PND01-03-samps / Age Group, Lineage, Cell class and subclass | 9.92e-06 | 174 | 73 | 5 | b4f3f5334803e5903bc496decf923f2e44f7fa3c | |
| ToppCell | facs-Heart-RA-24m-Endothelial-endothelial_cell_of_endocardium|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 9.92e-06 | 174 | 73 | 5 | 42dfb6f42b72e40e203b3ef341117bccf3553d54 | |
| ToppCell | facs-Heart-RA-24m-Endothelial-endocardial_cell|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 9.92e-06 | 174 | 73 | 5 | f04edf2ca6788875c9918611e416fb739924382e | |
| ToppCell | COVID-19-kidney-PCT-S3-2|kidney / Disease (COVID-19 only), tissue and cell type | 9.92e-06 | 174 | 73 | 5 | 5aa2fb631505600f37d2b87b02def7be139dc262 | |
| ToppCell | COVID-19-kidney-PCT-S3-2|COVID-19 / Disease (COVID-19 only), tissue and cell type | 1.05e-05 | 176 | 73 | 5 | b6497324e3e52f514ce556a3fa0c3011c45dcc7b | |
| ToppCell | E12.5-Mesenchymal-myocytic_cell-vascular_associated_smooth_muscle_cell|E12.5 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 1.08e-05 | 177 | 73 | 5 | 5cdf413f82376a95467322b16d10b0d1e7557e2d | |
| ToppCell | PND28-Endothelial-Endothelial_blood-vessel-Macrovascular_EC|PND28 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.08e-05 | 177 | 73 | 5 | 6f6cf93893daac6ae228df36219ee3acf8de8f97 | |
| ToppCell | 368C-Myeloid-Macrophage-SPP1+_Macrophage_3|Macrophage / Donor, Lineage, Cell class and subclass (all cells) | 1.08e-05 | 177 | 73 | 5 | eb0cfe8e9a91910f9979608ed47add48d98ce4dd | |
| ToppCell | 368C-Myeloid-Macrophage-SPP1+_Macrophage_3|Myeloid / Donor, Lineage, Cell class and subclass (all cells) | 1.11e-05 | 178 | 73 | 5 | 9d575902d3dbe33437c9d4200df093a741269803 | |
| ToppCell | droplet-Liver-LIVER_NPC-30m-Endothelial-nan|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.14e-05 | 179 | 73 | 5 | 025d414ec88d5680d99c8173e70ee3bb0b694f74 | |
| ToppCell | facs-Heart-RA-24m-Endothelial|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.17e-05 | 180 | 73 | 5 | 174c643e046646e3b305dd7e5b120d2c9a46690f | |
| ToppCell | Primary_Visual_cortex_(V1C)-Non-neuronal-Mesenchymal-Mes|Primary_Visual_cortex_(V1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.17e-05 | 180 | 73 | 5 | 1ade66352570a3f869e21e1055d0a65fbf56c61d | |
| ToppCell | droplet-Limb_Muscle-Pre-Sort|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.17e-05 | 180 | 73 | 5 | af2bafcd1b2082629de3ea336711add01565c4c4 | |
| ToppCell | Primary_Visual_cortex_(V1C)-Non-neuronal-Mesenchymal|Primary_Visual_cortex_(V1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.17e-05 | 180 | 73 | 5 | f118c580134bdf3027e2218690cfc8a93468c1ae | |
| ToppCell | droplet-Limb_Muscle-Pre-Sort-18m|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.17e-05 | 180 | 73 | 5 | f29a995cf6e1a1836ed68b73258d9370bf3d4434 | |
| ToppCell | PND10-Endothelial-Endothelial_blood-vessel-Macrovascular_EC-AEC-AEC_mature|PND10 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.20e-05 | 181 | 73 | 5 | 4d7793026373cbcf04b15c77f95f1025d07d4c00 | |
| ToppCell | PND10-Endothelial-Endothelial_blood-vessel-Macrovascular_EC-AEC|PND10 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.27e-05 | 183 | 73 | 5 | 3427f3cbe6ea81709750e7dd3ff378f03ae65eab | |
| ToppCell | droplet-Trachea-nan-3m-Endothelial|Trachea / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.30e-05 | 184 | 73 | 5 | fa5c3020e75fdde1363393dea97ebd99f1eae9ff | |
| ToppCell | droplet-Trachea-3m-Endothelial|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 1.30e-05 | 184 | 73 | 5 | ad520ab6bb776b5303df505b7e1afb22484f18a7 | |
| ToppCell | droplet-Heart-4Chambers-21m-Endothelial|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.30e-05 | 184 | 73 | 5 | f17d713af4a97dff4eeeab24c405677ef2ffcf84 | |
| ToppCell | droplet-Trachea-nan-3m-Endothelial-nan|Trachea / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.30e-05 | 184 | 73 | 5 | 1d63cb75a89c5f3f3b9ebf7fce8cb0fd4a92b645 | |
| ToppCell | droplet-Trachea-nan-3m-Endothelial-endothelial_cell|Trachea / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.30e-05 | 184 | 73 | 5 | 76caad53d55fff5acca27bf190a6de7b27437d9f | |
| ToppCell | droplet-Trachea-3m-Endothelial-endothelial_cell_of_trachea|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 1.30e-05 | 184 | 73 | 5 | 1fc1f0a3b4dbb085ebcc3960f67be24a108fe5b9 | |
| ToppCell | droplet-Trachea-3m-Endothelial-endothelial_cell_of_trachea-tracheal_endothelial_cell|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 1.30e-05 | 184 | 73 | 5 | 2467207aaea307873ab286f89cfc7668a227a694 | |
| ToppCell | droplet-Kidney-KIDNEY-30m-Epithelial-Pecam____Kidney_cortex_artery_cell|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.33e-05 | 185 | 73 | 5 | f98af3146ec2f44c30d31a662fb9c4fa3ca4f706 | |
| ToppCell | COVID-19-Heart-Fib_2|COVID-19 / Disease (COVID-19 only), tissue and cell type | 1.33e-05 | 185 | 73 | 5 | 8f95d8e591bf7379d13f5a0545b0cb49e2b1ab5d | |
| ToppCell | droplet-Fat-Mat-18m-Endothelial-nan|Fat / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.33e-05 | 185 | 73 | 5 | d9be5853acdda7b1ac819cf50c7940d1d2362d15 | |
| ToppCell | droplet-Heart-nan-18m-Endothelial|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.33e-05 | 185 | 73 | 5 | a32d5cb596ebac80eb1ac301055e65d420879ec8 | |
| ToppCell | 356C-Endothelial_cells-Endothelial-E-|356C / Donor, Lineage, Cell class and subclass (all cells) | 1.37e-05 | 186 | 73 | 5 | 2e024097ee361eeb1d855a4edb8ac8cdad35da06 | |
| ToppCell | 356C-Endothelial_cells-Endothelial-E|356C / Donor, Lineage, Cell class and subclass (all cells) | 1.37e-05 | 186 | 73 | 5 | c3449e54454009973818fc1101933c6f0168258c | |
| ToppCell | droplet-Lung-nan-3m-Endothelial-Vein_endothelial_cell|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.40e-05 | 187 | 73 | 5 | 64dd28b23eda7dfb7fd069be2742de7bad0fd87a | |
| ToppCell | droplet-Lung-nan-3m-Endothelial-vein_endothelial_cell|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.40e-05 | 187 | 73 | 5 | b535d5447bf15e95dcf025a0a455628b956fc857 | |
| ToppCell | droplet-Kidney-nan-18m-Epithelial-Pecam____Kidney_cortex_artery_cell|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.40e-05 | 187 | 73 | 5 | e93cad16a087d1443cbf4e1690dc1b35d7a84c41 | |
| ToppCell | droplet-Fat-SCAT-30m-Endothelial-Cd36+|Fat / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.44e-05 | 188 | 73 | 5 | e901a9bdf00b8e91806f445af66647373bf62661 | |
| ToppCell | wk_15-18-Endothelial-Blood_vessel_endothelial-GRIA2+_arterial_endo|wk_15-18 / Celltypes from embryonic and fetal-stage human lung | 1.44e-05 | 188 | 73 | 5 | 366a2d59b9c81d8a7659749f9c07efa46b49a39a | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Fibroblast-kidney_interstitial_fibroblast-Adaptive_/_Maladaptive_/_Repairing_Fibroblast|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 1.44e-05 | 188 | 73 | 5 | ce85a56ac27a6432421dde93a1bafa8b943244b9 | |
| ToppCell | COVID-19-Heart-Fib_1|COVID-19 / Disease (COVID-19 only), tissue and cell type | 1.44e-05 | 188 | 73 | 5 | fe361215f4ba841aa5e1e581fb56f2f4d3ccd201 | |
| ToppCell | kidney_cells-Renal_AKI_(acute_kidney_injury)-Endothelial-lymphatic_endothelial_cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 1.44e-05 | 188 | 73 | 5 | 26915db8863f4115b46a81982e187322e21600fd | |
| ToppCell | droplet-Fat-SCAT-30m-Endothelial-endothelial_cell|Fat / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.44e-05 | 188 | 73 | 5 | 5cf060bb8adaefa9964187195d67993c1248ef47 | |
| ToppCell | kidney_cells-Renal_AKI_(acute_kidney_injury)-Endothelial-lymphatic_endothelial_cell-lymphatic_endothelial_cell_of_renal_cortex|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 1.44e-05 | 188 | 73 | 5 | 3f76c0f912f8f023ea425be7f43593b3d7f967e3 | |
| ToppCell | 5'-Adult-LargeIntestine-Mesenchymal-fibroblastic-Stromal_2_(NPY+)|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.44e-05 | 188 | 73 | 5 | 997dcfc4f08738ab398d8abc15e4fd2fc6619862 | |
| ToppCell | 5'-Adult-Appendix-Endothelial-blood_vessel_EC-arterial_capillary|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.44e-05 | 188 | 73 | 5 | a11b12f1857953bcdbfb5f25e127f2350c39567d | |
| ToppCell | droplet-Fat-SCAT-30m-Endothelial|Fat / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.44e-05 | 188 | 73 | 5 | 449f9602df3c83b2110eb479a00d428d1b55b423 | |
| ToppCell | kidney_cells-Renal_AKI_(acute_kidney_injury)-Endothelial-lymphatic_endothelial_cell-lymphatic_endothelial_cell_of_renal_cortex-lymphatic_endothelial_cell_of_renal_cortex|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 1.44e-05 | 188 | 73 | 5 | 61ee7b152745164293d8a44ef91ee2393efbdca5 | |
| ToppCell | LPS-IL1RA-Stromal_mesenchymal-Matrix_Fibroblast-Diff_MatrixFB|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.48e-05 | 189 | 73 | 5 | e9d5e858e320c6e9913c1ea6a54967d21eda605f | |
| ToppCell | droplet-Limb_Muscle-Pre-Sort-18m-Endothelial-nan|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.48e-05 | 189 | 73 | 5 | d9c2adbbe3e40eb8d57200b6411533e6685ea0d2 | |
| ToppCell | tumor_Lung-Fibroblasts-Pericytes|Fibroblasts / Location, Cell class and cell subclass | 1.48e-05 | 189 | 73 | 5 | 9c407b17d7945e81e1ae6c18452f5d20fb09d563 | |
| ToppCell | PND07-Endothelial-Endothelial_blood-vessel-Macrovascular_EC-AEC-AEC_mature|PND07 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.48e-05 | 189 | 73 | 5 | 9da012fdfa9a8d488cab710a463a1d70e89f990c | |
| ToppCell | droplet-Limb_Muscle-Pre-Sort-18m-Endothelial-endothelial_cell|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.48e-05 | 189 | 73 | 5 | 476226787c8ea0c9834a6f4c99ac7091cc20a455 | |
| ToppCell | P03-Mesenchymal-myocytic_cell-vascular_associated_smooth_muscle_cell|P03 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 1.48e-05 | 189 | 73 | 5 | b5439ef221106f6d54434f268485e9bb17b39102 | |
| ToppCell | droplet-Limb_Muscle-Pre-Sort-18m-Endothelial|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.48e-05 | 189 | 73 | 5 | 3fe69bad6427e41b8d2dae450828cc21e9c3b3ad | |
| ToppCell | droplet-Trachea-3m-Endothelial-endothelial_cell_of_trachea-tracheal_endothelial_cell-tracheal_endothelial_cell_l10|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 1.48e-05 | 189 | 73 | 5 | 28b9e96a5206b7fdae9b17daf05c8f5d24b6c5ec | |
| ToppCell | facs-Lung-3m-Endothelial|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 1.52e-05 | 190 | 73 | 5 | d55b3ad4d1ec172b042bc08127506c354f87f69d | |
| ToppCell | E16.5-Mesenchymal-Mesenchymal_myocytic-Myofibroblast_vascular-Pericyte-Pericyte_mature|E16.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.52e-05 | 190 | 73 | 5 | 106862ef44fcaa0971c3ba0147d13eb08015ca77 | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Fibroblast-kidney_interstitial_fibroblast|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 1.52e-05 | 190 | 73 | 5 | efb757f11c2809e66ddb48a5c84f5433f111cb7c | |
| ToppCell | LPS-IL1RA-Endothelial-Endothelial-Artery|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.52e-05 | 190 | 73 | 5 | aed65d584ca0c25f6a8313c66b421a6618af82ea | |
| ToppCell | facs-SCAT-Fat-18m-Endothelial-nan|SCAT / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.52e-05 | 190 | 73 | 5 | b0c9dae8189d407c94964c6bfe3ef92035245357 | |
| ToppCell | 21-Trachea-Endothelial|Trachea / Age, Tissue, Lineage and Cell class | 1.52e-05 | 190 | 73 | 5 | bce09634acbc2cfd53666328e8aed8bf8835f845 | |
| ToppCell | facs-MAT-Fat-18m-Endothelial|MAT / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.52e-05 | 190 | 73 | 5 | 34e56c5e7ea6a8f227dbaefe73cbb8818d18b523 | |
| Computational | Cytochrome P450. | 1.16e-07 | 14 | 37 | 4 | MODULE_106 | |
| Computational | Neighborhood of IGFBP1 | 4.12e-05 | 57 | 37 | 4 | CAR_IGFBP1 | |
| Computational | Genes in the cancer module 135. | 8.20e-05 | 25 | 37 | 3 | MODULE_135 | |
| Computational | Metal / Ca ion binding. | 8.53e-05 | 133 | 37 | 5 | MODULE_324 | |
| Computational | Neighborhood of IGF1 | 9.24e-05 | 26 | 37 | 3 | GNF2_IGF1 | |
| Computational | Adhesion molecules. | 1.12e-04 | 141 | 37 | 5 | MODULE_122 | |
| Computational | Placenta genes. | 1.43e-04 | 463 | 37 | 8 | MODULE_38 | |
| Computational | DRG (dorsal root ganglia) genes. | 2.86e-04 | 384 | 37 | 7 | MODULE_2 | |
| Computational | Genes upregulated in subsets of cells of a given type within various tumors | 6.58e-04 | 50 | 37 | 3 | GAVISH_3CA_METAPROGRAM_ENDOTHELIAL_ENDO_1 | |
| Computational | Neighborhood of CEBPA | 1.35e-03 | 64 | 37 | 3 | GNF2_CEBPA | |
| Computational | Ovary genes. | 1.46e-03 | 368 | 37 | 6 | MODULE_1 | |
| Computational | Genes in the cancer module 55. | 1.65e-03 | 832 | 37 | 9 | MODULE_55 | |
| Computational | Heart, liver, kidney and pancreas metabolic and xenobiotic response genes. | 1.69e-03 | 835 | 37 | 9 | MODULE_88 | |
| Computational | Oxidoreductases. | 2.55e-03 | 22 | 37 | 2 | MODULE_373 | |
| Computational | Liver genes - metabolism and xenobiotics. | 2.72e-03 | 563 | 37 | 7 | MODULE_23 | |
| Computational | Neighborhood of CDH11 | 3.29e-03 | 25 | 37 | 2 | GNF2_CDH11 | |
| Computational | Neighborhood of PRKCA | 3.33e-03 | 181 | 37 | 4 | MORF_PRKCA | |
| Computational | Lung genes. | 3.36e-03 | 434 | 37 | 6 | MODULE_5 | |
| Drug | 4',5-dihydroxydiclofenac | 1.37e-09 | 6 | 72 | 4 | CID003052567 | |
| Drug | 3'-hydroxydiclofenac | 1.37e-09 | 6 | 72 | 4 | CID000112230 | |
| Drug | omeprazole | 3.19e-08 | 101 | 72 | 7 | CID000004594 | |
| Drug | 5-hydroxydiclofenac | 4.46e-08 | 12 | 72 | 4 | CID003052566 | |
| Drug | walrycin A | 5.17e-08 | 32 | 72 | 5 | ctd:C574123 | |
| Drug | 2'-(glutathion-S-yl)-deschlorodiclofenac | 1.22e-07 | 15 | 72 | 4 | ctd:C586542 | |
| Drug | N-benzylformamide | 1.48e-07 | 76 | 72 | 6 | CID000080654 | |
| Drug | Azamulinum | 2.72e-07 | 18 | 72 | 4 | CID003086060 | |
| Drug | D 703 | 2.72e-07 | 18 | 72 | 4 | CID000054088 | |
| Drug | bufuralol | 3.02e-07 | 5 | 72 | 3 | ctd:C010831 | |
| Drug | hydroxytolbutamide | 3.44e-07 | 19 | 72 | 4 | CID000003656 | |
| Drug | 2cgu | 4.23e-07 | 48 | 72 | 5 | CID003506204 | |
| Drug | 3C etc | 4.29e-07 | 20 | 72 | 4 | CID000164045 | |
| Drug | 4,4'-cyclohexylidenebisphenol | 6.02e-07 | 6 | 72 | 3 | ctd:C570106 | |
| Drug | AC1O5Z5L | 6.02e-07 | 6 | 72 | 3 | CID006443527 | |
| Drug | 5-fluorotryptamine | 1.05e-06 | 7 | 72 | 3 | ctd:C034536 | |
| Drug | 6-Fluoro-6-desoxyoxymorphone | 1.05e-06 | 7 | 72 | 3 | CID005486899 | |
| Drug | 16-O-demethylaconitine | 1.05e-06 | 7 | 72 | 3 | ctd:C486136 | |
| Drug | Tolbutamide | 1.11e-06 | 25 | 72 | 4 | ctd:D014044 | |
| Drug | 1,4-naphthoquinone | 1.30e-06 | 26 | 72 | 4 | ctd:C035342 | |
| Drug | 13-hydroxyeicosatetraenoic acid | 1.68e-06 | 8 | 72 | 3 | CID006439499 | |
| Drug | 11-HODE | 1.68e-06 | 8 | 72 | 3 | CID006438497 | |
| Drug | 5-bromotryptamine | 1.68e-06 | 8 | 72 | 3 | ctd:C040997 | |
| Drug | 1-(3-(4-phenoxyphenoxy)-2-oxopropyl)indole-5-carboxylic acid | 1.68e-06 | 8 | 72 | 3 | ctd:C585955 | |
| Drug | (hydrochloride) | 2.06e-06 | 29 | 72 | 4 | CID000004923 | |
| Drug | 4,5-dihydropyrazole-1,5-dicarboxylic acid 1-((4-chlorophenyl)-amide) 5-(2-oxo-2H-(1,3')bipyridinyl-6'-yl)-amide | 2.51e-06 | 9 | 72 | 3 | ctd:C545880 | |
| Drug | Acenocoumarol | 2.51e-06 | 9 | 72 | 3 | ctd:D000074 | |
| Drug | 5-chlorotryptamine | 2.51e-06 | 9 | 72 | 3 | ctd:C529169 | |
| Drug | 3-(2-(4-(3-chloro-2-methylphenyl)1-piperazinyl)ethyl)5,6-dimethoxy-1-(4-imidazolylmethyl)-1H-indazol dihydrochloride 3.5 hydrate | 2.51e-06 | 9 | 72 | 3 | ctd:C109602 | |
| Drug | 5-(N-(4-((4-ethylbenzyl)thio)phenyl)sulfamoyl)-2-methylbenzoic acid | 2.51e-06 | 9 | 72 | 3 | ctd:C000588958 | |
| Drug | Tryptamines | 2.51e-06 | 9 | 72 | 3 | ctd:D014363 | |
| Drug | (Z) Fluvoxamine | 2.64e-06 | 69 | 72 | 5 | CID000003404 | |
| Drug | BP-7,8-oxide | 3.09e-06 | 32 | 72 | 4 | CID000037455 | |
| Drug | chloral hydrate | 3.39e-06 | 129 | 72 | 6 | CID000002707 | |
| Drug | 2,2,2-trichloroethanol | 3.49e-06 | 73 | 72 | 5 | CID000008259 | |
| Drug | AC1L1CUL | 3.58e-06 | 10 | 72 | 3 | CID000002070 | |
| Drug | sitaxsentan | 3.58e-06 | 10 | 72 | 3 | ctd:C106276 | |
| Drug | norketobemidone | 3.58e-06 | 10 | 72 | 3 | CID000161154 | |
| Drug | Haloperidol metabolite I | 4.91e-06 | 11 | 72 | 3 | CID000038282 | |
| Drug | trans-1,2-dihydro-1,2-naphthalenediol | 4.91e-06 | 11 | 72 | 3 | ctd:C507866 | |
| Drug | 4-(N-propionylanilino)piperidine | 6.54e-06 | 12 | 72 | 3 | CID000259381 | |
| Drug | 4-hydroxyretinoic acid | 6.54e-06 | 12 | 72 | 3 | ctd:C019429 | |
| Drug | carveol | 6.54e-06 | 12 | 72 | 3 | CID000007438 | |
| Drug | desethylamodiaquine | 6.54e-06 | 12 | 72 | 3 | ctd:C047386 | |
| Drug | norclozapine | 6.54e-06 | 12 | 72 | 3 | ctd:C058272 | |
| Drug | 2 E1 | 6.65e-06 | 145 | 72 | 6 | CID006102788 | |
| Drug | emend | 7.71e-06 | 40 | 72 | 4 | CID000151165 | |
| Drug | AC1L18GM | 8.48e-06 | 13 | 72 | 3 | CID000000092 | |
| Drug | 7-hydroxyquinoline | 8.48e-06 | 13 | 72 | 3 | CID000011378 | |
| Drug | 1'-hydroxymidazolam | 8.48e-06 | 13 | 72 | 3 | CID000107917 | |
| Drug | clozapine N-oxide | 8.48e-06 | 13 | 72 | 3 | CID000036727 | |
| Drug | furafylline | 8.52e-06 | 41 | 72 | 4 | CID000003433 | |
| Drug | 14(15)-EpETrE | 9.27e-06 | 89 | 72 | 5 | CID000001431 | |
| Drug | dibenzylfluorescein | 9.86e-06 | 2 | 72 | 2 | ctd:C558664 | |
| Drug | tranylcypromine | 1.03e-05 | 91 | 72 | 5 | CID000005530 | |
| Drug | 5-MeO-DIPT | 1.08e-05 | 14 | 72 | 3 | CID000151182 | |
| Drug | propionanilide | 1.08e-05 | 14 | 72 | 3 | CID000012107 | |
| Drug | 2-pentanol | 1.08e-05 | 14 | 72 | 3 | CID000022386 | |
| Drug | sulfaphenazole | 1.13e-05 | 44 | 72 | 4 | CID000005335 | |
| Drug | polybrominated biphenyl | 1.13e-05 | 44 | 72 | 4 | CID000042948 | |
| Drug | 4-hydroxymephenytoin | 1.34e-05 | 15 | 72 | 3 | CID000119507 | |
| Drug | 4,4'-(hexafluoroisopropylidene)diphenol | 1.65e-05 | 16 | 72 | 3 | ctd:C571725 | |
| Drug | Amodiaquine | 1.65e-05 | 16 | 72 | 3 | ctd:D000655 | |
| Drug | 6-hydroxychlorzoxazone | 1.65e-05 | 16 | 72 | 3 | CID000002734 | |
| Drug | 1-phenylazo-2-naphthol | 1.65e-05 | 16 | 72 | 3 | ctd:C024336 | |
| Drug | 1,1,1-trichloro-2-(4-hydroxyphenyl)-2-(4-methoxyphenyl)ethane | 1.65e-05 | 16 | 72 | 3 | ctd:C495657 | |
| Drug | 19-HETE | 1.75e-05 | 49 | 72 | 4 | CID006439528 | |
| Drug | 6-hydroxymelatonin | 1.90e-05 | 50 | 72 | 4 | CID000001864 | |
| Drug | diosmetin | 2.00e-05 | 17 | 72 | 3 | ctd:C039602 | |
| Drug | 7-benzyloxyquinoline | 2.39e-05 | 18 | 72 | 3 | CID003035604 | |
| Drug | pleuromutilin | 2.39e-05 | 18 | 72 | 3 | CID000031326 | |
| Drug | 2,4-oxazolidinedione | 2.39e-05 | 18 | 72 | 3 | CID000097389 | |
| Drug | triazolam | 2.58e-05 | 54 | 72 | 4 | CID000005556 | |
| Drug | D 617 | 2.83e-05 | 19 | 72 | 3 | CID000093168 | |
| Drug | 6|A-Hydroxycortisol | 2.83e-05 | 19 | 72 | 3 | CID000150985 | |
| Drug | 5-(4-(3-(4-cyclohexyl-2-propylphenoxy)propoxy)phenyl)-1,3-oxazolidine-2,4-dione | 2.95e-05 | 3 | 72 | 2 | ctd:C502236 | |
| Drug | 4-Iodopyrazole | 2.95e-05 | 3 | 72 | 2 | DB02721 | |
| Drug | picoxystrobin | 2.95e-05 | 3 | 72 | 2 | ctd:C556557 | |
| Drug | 2-hydroxychlorpropamide | 2.95e-05 | 3 | 72 | 2 | CID003082454 | |
| Drug | Cyclohexenes | 2.95e-05 | 3 | 72 | 2 | ctd:D053138 | |
| Drug | mono-N-demethyladinazolam | 2.95e-05 | 3 | 72 | 2 | ctd:C050132 | |
| Drug | ortho-Aminobenzoates | 2.95e-05 | 3 | 72 | 2 | ctd:D062367 | |
| Drug | Delavirdine | 2.95e-05 | 3 | 72 | 2 | ctd:D020008 | |
| Drug | Quinidine | 2.98e-05 | 56 | 72 | 4 | ctd:D011802 | |
| Drug | N'-nitrosoanatabine | 3.33e-05 | 20 | 72 | 3 | CID000051291 | |
| Drug | tamoxifen N-oxide | 3.33e-05 | 20 | 72 | 3 | CID003033895 | |
| Drug | 3-methoxymorphinan | 3.33e-05 | 20 | 72 | 3 | CID000001671 | |
| Drug | chloroquine | 3.52e-05 | 288 | 72 | 7 | CID000002719 | |
| Drug | AC-474 | 3.67e-05 | 59 | 72 | 4 | CID000002999 | |
| Drug | benzphetamine | 3.79e-05 | 119 | 72 | 5 | CID000002341 | |
| Drug | AC1L21VM | 3.87e-05 | 21 | 72 | 3 | CID000039524 | |
| Drug | nirvanol | 3.87e-05 | 21 | 72 | 3 | CID000091480 | |
| Drug | zafirlukast | 3.87e-05 | 21 | 72 | 3 | ctd:C062735 | |
| Drug | terfenadine | 4.19e-05 | 61 | 72 | 4 | CID000005405 | |
| Drug | Lansoprazole | 4.19e-05 | 61 | 72 | 4 | ctd:D064747 | |
| Drug | BP-4,5-oxide | 4.19e-05 | 61 | 72 | 4 | CID000037786 | |
| Drug | N'-nitrosoanabasine | 4.47e-05 | 22 | 72 | 3 | CID000014335 | |
| Drug | azoline | 4.47e-05 | 22 | 72 | 3 | CID003013050 | |
| Drug | AC1L1V2E | 4.47e-05 | 22 | 72 | 3 | CID000010376 | |
| Drug | Quinine | 4.47e-05 | 22 | 72 | 3 | ctd:D011803 | |
| Disease | X-21258 measurement | 1.12e-08 | 3 | 67 | 3 | EFO_0800802 | |
| Disease | pulse pressure measurement | FNDC3B CYP2C9 FBN1 FBN2 CRIM1 PXDNL LRP1 LAMA5 FBXL17 ODF1 NNT NOTCH3 ADH1B ADH1C | 2.37e-06 | 1392 | 67 | 14 | EFO_0005763 |
| Disease | X-14473 measurement | 5.08e-06 | 2 | 67 | 2 | EFO_0021370 | |
| Disease | central corneal thickness | 6.55e-06 | 309 | 67 | 7 | EFO_0005213 | |
| Disease | ecosanoids measurement | 7.59e-06 | 55 | 67 | 4 | EFO_0020044 | |
| Disease | cyclo(leu-pro) measurement | 1.52e-05 | 3 | 67 | 2 | EFO_0800676 | |
| Disease | connective tissue disease (implicated_via_orthology) | 1.52e-05 | 3 | 67 | 2 | DOID:65 (implicated_via_orthology) | |
| Disease | Carcinoma, Pancreatic Ductal | 2.19e-05 | 24 | 67 | 3 | C0887833 | |
| Disease | scoliosis (is_implicated_in) | 3.04e-05 | 4 | 67 | 2 | DOID:0060249 (is_implicated_in) | |
| Disease | S-6-hydroxywarfarin to S-warfarin ratio measurement | 4.90e-05 | 88 | 67 | 4 | EFO_0803332 | |
| Disease | Alcohol dependence | 5.06e-05 | 5 | 67 | 2 | cv:C0001973 | |
| Disease | ALCOHOL DEPENDENCE | 5.06e-05 | 5 | 67 | 2 | 103780 | |
| Disease | alcohol dependence | 6.14e-05 | 183 | 67 | 5 | MONDO_0007079 | |
| Disease | S-warfarin to R-warfarin ratio measurement | 6.62e-05 | 95 | 67 | 4 | EFO_0803331 | |
| Disease | adenocarcinoma (implicated_via_orthology) | 1.06e-04 | 7 | 67 | 2 | DOID:299 (implicated_via_orthology) | |
| Disease | glycine conjugate of C10H14O2 (1) measurement | 1.06e-04 | 7 | 67 | 2 | EFO_0800655 | |
| Disease | central nervous system cancer (implicated_via_orthology) | 1.06e-04 | 7 | 67 | 2 | DOID:3620 (implicated_via_orthology) | |
| Disease | Alcohol Use Disorder | 1.39e-04 | 44 | 67 | 3 | C0001956 | |
| Disease | Scoliosis, unspecified | 1.41e-04 | 8 | 67 | 2 | C0036439 | |
| Disease | mesangial proliferative glomerulonephritis (biomarker_via_orthology) | 1.41e-04 | 8 | 67 | 2 | DOID:4783 (biomarker_via_orthology) | |
| Disease | hemangiopericytoma (is_marker_for) | 1.81e-04 | 9 | 67 | 2 | DOID:264 (is_marker_for) | |
| Disease | plasma clozapine-to-N-desmethylclozapine ratio measurement | 1.81e-04 | 9 | 67 | 2 | EFO_0600040 | |
| Disease | pulmonary fibrosis (biomarker_via_orthology) | 2.03e-04 | 50 | 67 | 3 | DOID:3770 (biomarker_via_orthology) | |
| Disease | aortic aneurysm | 2.26e-04 | 10 | 67 | 2 | EFO_0001666 | |
| Disease | Familial thoracic aortic aneurysm and aortic dissection | 2.42e-04 | 53 | 67 | 3 | C4707243 | |
| Disease | nervous system disorder | 2.42e-04 | 53 | 67 | 3 | C0027765 | |
| Disease | X-11308 measurement | 2.76e-04 | 11 | 67 | 2 | EFO_0800693 | |
| Disease | platelet component distribution width | 3.05e-04 | 755 | 67 | 8 | EFO_0007984 | |
| Disease | thymol sulfate measurement | 3.30e-04 | 12 | 67 | 2 | EFO_0021170 | |
| Disease | Malignant neoplasm of skin | 3.32e-04 | 59 | 67 | 3 | C0007114 | |
| Disease | Skin Neoplasms | 3.32e-04 | 59 | 67 | 3 | C0037286 | |
| Disease | Migraine Disorders | 3.90e-04 | 13 | 67 | 2 | C0149931 | |
| Disease | FEV/FEC ratio | FNDC3B FBN1 CRIM1 MEGF6 LRP1 FBXL17 GSX2 TEKT5 ZBTB42 SLC30A10 | 4.30e-04 | 1228 | 67 | 10 | EFO_0004713 |
| Disease | Proteinuria | 5.23e-04 | 15 | 67 | 2 | HP_0000093 | |
| Disease | distal arthrogryposis (implicated_via_orthology) | 5.23e-04 | 15 | 67 | 2 | DOID:0050646 (implicated_via_orthology) | |
| Disease | 16a-hydroxy DHEA 3-sulfate measurement | 5.23e-04 | 15 | 67 | 2 | EFO_0800301 | |
| Disease | corneal resistance factor | 5.60e-04 | 451 | 67 | 6 | EFO_0010067 | |
| Disease | alcohol use disorder (is_implicated_in) | 5.97e-04 | 16 | 67 | 2 | DOID:1574 (is_implicated_in) | |
| Disease | andro steroid monosulfate C19H28O6S (1) measurement | 5.97e-04 | 16 | 67 | 2 | EFO_0800305 | |
| Disease | serum alanine aminotransferase measurement | 7.70e-04 | 869 | 67 | 8 | EFO_0004735 | |
| Disease | metabolonic lactone sulfate measurement | 8.47e-04 | 19 | 67 | 2 | EFO_0800659 | |
| Disease | amino acid measurement | 8.64e-04 | 678 | 67 | 7 | EFO_0005134 | |
| Disease | peak expiratory flow | 9.37e-04 | 498 | 67 | 6 | EFO_0009718 | |
| Disease | chronic obstructive pulmonary disease | 9.41e-04 | 688 | 67 | 7 | EFO_0000341 | |
| Disease | sex interaction measurement, cerebral amyloid angiopathy | 1.04e-03 | 21 | 67 | 2 | EFO_0006790, EFO_0008343 | |
| Disease | saturated fatty acids to total fatty acids percentage | 1.04e-03 | 21 | 67 | 2 | EFO_0022305 | |
| Disease | gout | 1.04e-03 | 196 | 67 | 4 | EFO_0004274 | |
| Disease | susceptibility to plantar warts measurement | 1.14e-03 | 90 | 67 | 3 | EFO_0008406 | |
| Disease | platelet reactivity measurement, response to clopidogrel | 1.25e-03 | 23 | 67 | 2 | EFO_0004985, GO_1903493 | |
| Disease | Sensorineural Hearing Loss (disorder) | 1.25e-03 | 23 | 67 | 2 | C0018784 | |
| Disease | migraine disorder | 1.32e-03 | 357 | 67 | 5 | MONDO_0005277 | |
| Disease | Squamous cell carcinoma of esophagus | 1.33e-03 | 95 | 67 | 3 | C0279626 | |
| Disease | alcohol use disorder measurement, alcohol dependence | 1.36e-03 | 24 | 67 | 2 | EFO_0009458, MONDO_0007079 | |
| Disease | systemic scleroderma (is_implicated_in) | 1.36e-03 | 24 | 67 | 2 | DOID:418 (is_implicated_in) | |
| Disease | alcohol use disorder measurement | 1.44e-03 | 214 | 67 | 4 | EFO_0009458 | |
| Disease | parental emotion expression measurmement, conduct disorder | 1.47e-03 | 25 | 67 | 2 | EFO_0004216, EFO_0008342 | |
| Disease | systemic mastocytosis | 1.47e-03 | 25 | 67 | 2 | MONDO_0016586 | |
| Disease | Acute Kidney Insufficiency | 1.59e-03 | 101 | 67 | 3 | C1565662 | |
| Disease | Acute kidney injury | 1.59e-03 | 101 | 67 | 3 | C2609414 | |
| Disease | Kidney Failure, Acute | 1.59e-03 | 101 | 67 | 3 | C0022660 | |
| Disease | brain cancer (implicated_via_orthology) | 1.59e-03 | 26 | 67 | 2 | DOID:1319 (implicated_via_orthology) | |
| Disease | Liver Cirrhosis | 1.68e-03 | 103 | 67 | 3 | C0023890 | |
| Disease | Fibrosis, Liver | 1.78e-03 | 105 | 67 | 3 | C0239946 | |
| Disease | hypertension (biomarker_via_orthology) | 1.79e-03 | 227 | 67 | 4 | DOID:10763 (biomarker_via_orthology) | |
| Disease | revision of total joint arthroplasty | 1.85e-03 | 28 | 67 | 2 | EFO_0020974 | |
| Disease | colorectal cancer (implicated_via_orthology) | 2.12e-03 | 30 | 67 | 2 | DOID:9256 (implicated_via_orthology) | |
| Disease | spontaneous coronary artery dissection | 2.26e-03 | 31 | 67 | 2 | EFO_0010820 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| PCCAGLVLFLGCSIP | 71 | Q9P2K9 | |
| EDCGKPCGPILCSIN | 186 | Q9Y6Y1 | |
| CLCPASGAKPKLSGF | 6 | Q13829 | |
| IPLFTPQCGKCRVCK | 91 | P00325 | |
| IPLFTPQCGKCRICK | 91 | P00326 | |
| QVCCCVGPSTPSLDK | 431 | P35348 | |
| CAPGFCFPGVACIQT | 91 | P49747 | |
| QCCCQVLKPGGSLFI | 236 | Q9NZJ6 | |
| PTFILGCAPCNVICS | 166 | P10632 | |
| CLCPPGFSGNFCEIV | 156 | P80370 | |
| VGRCLNSQPCCLPLG | 46 | Q8NET1 | |
| VLLCGCCPGGNLSNL | 171 | Q96EP9 | |
| RCCPEALGKLFPGLC | 11 | Q7Z418 | |
| LCFCLKGTTGPNCEI | 626 | P46531 | |
| GTCLDLPNTYKCSCP | 1196 | P46531 | |
| TCLCLGPFTGPECQF | 1371 | P46531 | |
| CVPKSGTDIVCLCPY | 2386 | Q5T1H1 | |
| CRCPTGFTGPKCTQQ | 4256 | Q07954 | |
| PSRKSGAFCVCPLCV | 51 | Q9BZM3 | |
| LKISGPCIVCSCIAG | 216 | Q9NRY7 | |
| ILKIVGPCVTCGCFG | 186 | A0PG75 | |
| CDPKSGVCSCPSGLQ | 156 | Q5VY43 | |
| CSCPPGTLGVLCEIN | 1146 | Q9UM47 | |
| SCGKVCGKPLPCGSL | 621 | Q12986 | |
| FGTKCAACQLGIPPT | 86 | Q9UBR4 | |
| CGLFSFPCKNGRCVP | 1026 | P98164 | |
| QICLPVPGGLFSCAC | 2031 | P98164 | |
| CSVGFIPVDGCICPK | 731 | P98088 | |
| FPLCQLCGCSPAGTL | 581 | O15230 | |
| CGSYVACPASCKVIP | 71 | A5LHX3 | |
| KPFGPIINGCCCLEE | 601 | Q9ULW8 | |
| GLGSCVKIESPCYPC | 191 | Q14990 | |
| VPSKCPAGTCDGCTF | 851 | A8MWY0 | |
| CAQCKASLLGCPFLP | 281 | Q96MT3 | |
| GLPCPSRCLCFKSTV | 21 | A1KZ92 | |
| PTFILGCAPCNVICS | 166 | P33261 | |
| CGCGPKCKETPLELV | 786 | Q2UY09 | |
| SCLSTCLAGCFLPVP | 76 | Q6ZN03 | |
| KGSREQGCLCPCPAS | 436 | Q8NFT6 | |
| SCTCPPGFYGKICEL | 351 | O00548 | |
| CRNTPGSFVCTCPKG | 781 | P35555 | |
| PCTLCQVDPICGKGY | 886 | P35555 | |
| KAPCISCTPDGCVLV | 771 | Q53EP0 | |
| VCKRKGAGVPACTPC | 196 | Q9UF56 | |
| KCPELSCSKICPLGF | 566 | Q9NZV1 | |
| CLPQTKGATNIICPC | 66 | Q6UWE3 | |
| VASLKGGPLCSCCVP | 171 | A6NNA5 | |
| LPLQQCCVKGPSFCS | 11 | Q5T749 | |
| CKPVLCVASFCPTSG | 76 | P60329 | |
| PTFILGCAPCNVICS | 166 | P33260 | |
| PTFILGCAPCNVICS | 166 | P11712 | |
| LCVNTLGGFTCKCPP | 2546 | P35556 | |
| GCVNTKGSYECVCPP | 376 | Q8IWY4 | |
| SCVLGIYPQCVLCPK | 246 | Q92613 | |
| CICKNPGTQKSCVPL | 616 | Q56UN5 | |
| PKLCIQLTVGSCFCG | 166 | Q8NGW6 | |
| CVNTPGSYLCECKPG | 176 | O75095 | |
| GCSCPLLSNLGSCKG | 11 | Q13423 | |
| SASGVFCCPLCRKPC | 46 | Q6P9F5 | |
| PSGCPVCGKVFSCRS | 901 | P57071 | |
| KDYPTCVSCGCNPVG | 446 | P25391 | |
| ICVKTPCLPGTCSCL | 76 | Q53H47 | |
| SYCGPKKCCGLTSLP | 11 | Q96M29 | |
| LCPGCKNSIPYCIAT | 1266 | Q8NEZ3 | |
| SFSCLCPPGRTGLLC | 376 | Q99466 | |
| FICHCPKGFEGPTCS | 1071 | Q99466 | |
| CSCLKELPPNGPFCL | 151 | Q8IZF2 | |
| TCGCAQRPSIPCSGK | 206 | Q8WW14 | |
| SKGCAKQLCCPPGAL | 406 | Q6XR72 | |
| TKPFVCPVAGCCARF | 511 | P98169 | |
| GKQIPCSSPGCCLSF | 106 | Q96IQ9 | |
| CPTAKAPTCGLCEVA | 2296 | P04275 | |
| KPGAGCPSRCLCFRT | 31 | Q92626 | |
| GPLCICPLCSKLFPS | 291 | B2RXF5 | |
| GVAPTCPLCGKTFSC | 331 | B2RXF5 | |
| GTKPFVCPVAGCCAR | 506 | P98168 | |
| PCPTCGKCFTKSSNL | 421 | Q5T619 | |
| CALKQCCGTLPQAPS | 441 | Q9Y6M5 | |
| ASLLCCGPKLAACGI | 41 | Q6P5S7 | |
| CPECGQPCSQKSGLI | 376 | Q9BS31 |